EurekaMag Full Text Articles Chapter 44,706

Nord, E. 1995: The person-trade-off approach to valuing health care programs. Medical Decision Making: An International Journal of the Society for Medical Decision Making 15(3): 201-208

Speransky, L.S.; Bocharov, V.J.; Goncharov, N.I.; van Calcar, J.S.; Vesalius, A. 1983: The personages of Jan Stephan van Calcar's frontispiece to Andreas Vesalius' book "On the Structure of the Human Body". Anatomischer Anzeiger 153(5): 465-479

Langmead, W.A.; O'Connor, D.T. 1969: The personal Centripeter--a particle size-selective personal air sampler. Annals of Occupational Hygiene 12(4): 185-195

Koff, E.; Rierdan, J.; Jacobson, S. 1981: The personal and interpersonal significance of menarche. Journal of the American Academy of Child Psychiatry 20(1): 148-158

Johnson, S.M.; Lobitz, G.K. 1974: The personal and marital adjustment of parents as related to observed child deviance and parenting behaviors. Journal of Abnormal Child Psychology 2(3): 193-207

Avery, J.K. 1984: The personal appearance. Journal of the Tennessee Medical Association 77(11): 666

Gorry, G.A. 1981: The personal computer and clinical practice. Archives of Internal Medicine 141(13): 1745-1746

Sladen, J.G. 1984: The personal computer as a clinical research and teaching tool. American Journal of Surgery 147(5): 654-659

Minifie, F.D. 1984: The personal computer as a professional tool. Asha 26(6): 23-25

Santoro, A.; Spongano, M.; Degli Esposti, E.; Sturani, A.; Galigani, A.; Zuccalà, A.; Zucchelli, P. 1985: The personal computer in a dialysis unit. Contributions to Nephrology 48: 43-55

Kay, S. 1966: The personal doctor's role in prevention. Journal of the College of General Practitioners 11suppl. 2: Suppl. 2: 58-64

Richards, J.C. 1974: The personal doctor--a luxury or a necessity?. New Zealand Medical Journal 79(510): 732-734

Forsyth, G. 1969: The personal doctor: retrospect and prospect. Journal of the Royal College of General Practitioners 17: Suppl. 1: 7-14

Coomer, O.B. 1967: The personal equation in practice management. Dental Clinics of North America 1967: 461-474

Neubürger, K. 1966: The personal experience of aging. Münchener Medizinische Wochenschrift 108(39): 1897-1901

Ezekiel, R.S. 1968: The personal future and Peace Corps competence. Journal of Personality and Social Psychology 8(Suppl 2): 1-26

Melges, F.T.; Anderson, R.E.; Kraemer, H.C.; Tinklenberg, J.R.; Weisz, A.E. 1971: The personal future and self-esteem. Archives of General Psychiatry 25(6): 494-497

Bisiani, M. 1965: The personal hygiene of athletes. Il Friuli Medico 20(6): 1114-1118

Foulds, G.A. 1971: The personal illness continuum. British Journal of Social and Clinical Psychology 10(4): 387

Ward, W.D. 1968: The personal injury claim. Medico-Legal Journal 36(1): 37-45

Nielsen, L.D. 1994: The personal liability of trustees and how to minimize it. Northwest Dentistry 73(4): 44-46

Johansen, K.; Wendelbo, O. 1982: The personal medical literature file. An information retrieval system for the general practitioner. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(17-18): 980-982

Herman, T.S. 1983: The personal microcomputer: its operation and application in the laboratory. American Journal of Medical Technology 49(4): 219-225

Potamianou, A. 1985: The personal myth. Points and counterpoints. Psychoanalytic Study of the Child 40: 285-296

Wilson, S. 1994: The personal problem-solving side of the nursing process. Nurse Educator 19(4): 5

Hbson, R.F.; Shapiro, D.A. 1970: The personal questionnaire as a method of assessing change during psychotherapy. British Journal of Psychiatry: the Journal of Mental Science 117(541): 623-626

McCabe, R.B.; McCollum, J.D. 1972: The personal reactions of a stuttering adult to delayed auditory feedback. Journal of Speech and Hearing Disorders 37(4): 536-541

Anonymous 1969: The personal situation on April 1, 1969. Tidskrift for Sveriges Sjukskoterskor 36(17): 975-976

Schmiedeck, R. 1973: The personal sphere model. Trial of a graphic test for object relationships. Zeitschrift für Klinische Psychologie und Psychotherapie 21(2): 164-182

Lucchesi, P.F. 1967: The personal touch--by tape recorder. Modern Hospital 108(2): 41-44

Cottrell, D.J.; McCrorie, P.; Perrin, F. 1994: The personal tutor system: an evaluation. Medical Education 28(6): 544-549

Fortier, J.C. 1966: The personal value of each member makes the value of the hospital team. Les Cahiers du Nursing 39(12): 2-5

Hallie, P. 1981: The personal voyage of a student of ethics: from cruelty to goodness. Hastings Center Report 11(3): 23-28

Badian, N.A.; Ghublikian, M. 1983: The personal-social characteristics of children with poor mathematical computation skills. Journal of Learning Disabilities 16(3): 154-157

Roth, N.; Blackwell, E.; Anderson, E.G. 1971: The personalities of two pioneer medical women: Elizabeth Blackwell and Elizabeth Garrett Anderson. Bulletin of the new York Academy of Medicine 47(1): 67-79

Garcia, I. 1967: The personality. Adm; Revista de la Asociacion Dental Mexicana 24(4): 393-418

Eysenck, H.J.; Coulter, T.T. 1972: The personality and attitudes of working-class British Communists and Fascists. Journal of Social Psychology 87(1): 59-73

Pierson, G.R.; Moseley, J.; Olsen, M. 1967: The personality and character structure of the delinquent: some social psychological implications. Journal of Genetic Psychology 110(1st Half): 139-147

Cartwright, L.K. 1972: The personality and family background of a sample of women medical students at the University of California. Journal of the American Medical Women's Association 27(5): 260-266

Koegel, R.L.; Schreibman, L.; O'Neill, R.E.; Burke, J.C. 1983: The personality and family-interaction characteristics of parents of autistic children. Journal of Consulting and Clinical Psychology 51(5): 683-692

Bancroft, J.; Axworthy, D.; Ratcliffe, S. 1982: The personality and psycho-sexual development of boys with 47 XXY chromosome constitution. Journal of Child Psychology and Psychiatry and Allied Disciplines 23(2): 169-180

Herzka, H.S. 1981: The personality and the care of the mentally retarded child. Therapeutische Umschau. Revue Therapeutique 38(4): 297-302

Eberhard, G. 1968: The personality at peptic ulcer. Preliminary report of a twin study. Acta Psychiatrica Scandinavica. Supplementum 203: 131-133

L'vov, S.E.; Kornilova, G.I. 1994: The personality characteristics of patients with hand injuries. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 94(6): 16-18

Loprieno, M.; Ghetti Genovese, C. 1970: The personality concept in research on the style of perception and cognition. Giornale di Psichiatria E di Neuropatologia 98(2): 171-185

Rubins, J.L. 1974: The personality cult in psychoanalysis. American Journal of Psychoanalysis 34(2): 129-133

Kristianson, P. 1974: The personality in psychomotor epilepsy compared with the explosive and aggressive personality. British Journal of Psychiatry: the Journal of Mental Science 125(0): 221-229

Kline, R.B.; Lachar, D.; Sprague, D.J. 1985: The personality inventory for children (PIC): an unbiased predictor of cognitive and academic status. Journal of Pediatric Psychology 10(4): 461-477

Lefèvre, B.H.; Lefèvre, A.B. 1982: The personality of Antonio Branco Lefèvre. Revista do Hospital das Clinicas 37(5): 5 P Preceding 199

Vondrácek, V.; Heveroch, A. 1969: The personality of Antonín Herveroch (1869-1927) and his importance for the Czech science of psychology and psychiatry. Casopis Lekaru Ceskych 108(19): 571-574

Meyers, J. 1969: The personality of Belinda's Baron: Pope's 'The Rape of the Lock'. American Imago; a Psychoanalytic Journal for the Arts and Sciences 26(1): 71-77

Robinson, D. 1973: The personality of British businessmen. Proceedings of the Royal Society of Medicine 66(12): 1167-1169

Kovacs, A.R.; Nightingale, F. 1973: The personality of Florence Nightingale. International Nursing Review 20(3): 78-79 Passim

Benton, J.F.; Guibert 1970: The personality of Guibert of Nogent. Psychoanalytic Review 57(4): 563-586

Rintelen, F.; Jung, K.G. 1982: The personality of Karl Gustav Jung. Gesnerus 39(2): 237-242

Mesrobeanu, I.; Ionescu-Mihaeşti, C. 1972: The personality of Professor C. Ionescu-Mihaesti. His role and activity in the Institutul "Dr. I. Cantacuzino". II. Microbiologia Parazitologia Epidemiologia 17(3): 273-280

Fusco, A. 1967: The personality of a nurse--responsibility in the exercise of her functions. Boleettino d'Informazioni Della Consociazione Nazionale Infermiere Professionali E Assistenti Sanitarie Visitatrici 20(2): 25-26

Islam, M.F.; Abdel-Hay, M.M.; Gado, S.H. 1974: The personality of accident-prone drivers. Journal of the Egyptian Medical Association 57(7-8): 382-387

Ursea, N.; Dafinoiu, I. 1983: The personality of dialyzed patients. Revista de Medicina Interna Neurologe Psihiatrie Neurochirurgie Dermato-Venerologie. Medicina Interna 35(6): 571-576

Delteil, P.; Lasserre, P.; Abittan, J.; Josselin, F.; Douche, F.; Prieur, M. 1970: The personality of drug addicts and their treatment. Annales Medico-Psychologiques 2(1): 107-113

Nau, E. 1966: The personality of incest victims. Acta Medicinae Legalis et Socialis 19(2): 195-198

Hoy, R.M. 1969: The personality of inpatient alcoholics in relation to group psychotherapy, as measured by the 16-P.F. Quarterly Journal of Studies on Alcohol 30(2): 401-407

Colin, D.; Carbonnier, J.P. 1980: The personality of myopathic children. Neuropsychiatrie de l'Enfance et de l'Adolescence 28(1-2): 59-67

Jacob, A. 1969: The personality of patients in the "artificial practice". Journal of the Royal College of General Practitioners 17(82): 299-303

Metellus, J. 1980: The personality of patients with Broca's aphasias. Annales Medico-Psychologiques 138(7): 856-861

Precechtĕl, A.; Kutvirt, O. 1967: The personality of professor MUDr. Otakar Kutvirt. Ceskoslovenska Otolaryngologie 16(5): 257-263

Precechtĕl, A.; Hlavácek, V. 1968: The personality of professor Vladimír Hlavácek and his development as a scientific worker. Ceskoslovenska Otolaryngologie 17(4): 247-249

Westrin, C.G.; Hirsch, C.; Lindegård, B. 1972: The personality of the back patient. Clinical Orthopaedics and Related Research 87: 209-216

Sentenac, M. 1971: The personality of the breast cancer. Gynecologie Pratique 22(5): 457-458

Failla, E.; Grassi, B.; Petta, A. 1968: The personality of the chronic alcoholic studied with the Rosenzweig and Bernreuter tests. Rassegna di Neuropsichiatria E Scienze Affini 22(3): 273-297

Müller, K. 1971: The personality of the epileptic. Zeitschrift für Arztliche Fortbildung 65(8): 422-425

Dugas, M.; Velin, J.; Guillarme, J.J.; Bobet, R. 1974: The personality of the epileptic child. Psychometric study. Revue de Neuropsychiatrie Infantile et d'Hygiene Mentale de l'Enfance 22(3): 189-198

Balák, K. 1983: The personality of the gynecologist. Ceskoslovenska Gynekologie 48(3): 161-162

Mares, J.; Rybárová, M.; Strnad, L. 1981: The personality of the medical student and methods for its study. Ceskoslovenske Zdravotnictvi 29(8-9): 355-358

Levitt, L.P. 1966: The personality of the medical student. a brief historical review and contemporary psychiatric study. Chicago Medical School Quarterly 25(4): 201-214

Melísková, M. 1971: The personality of the middle medical school student. Zdravotnicka Pracovnice 21(9): 442-443

Bochnik, H.J.; Gärtner-Huth, C. 1984: The personality of the patient as a diagnostic and therapeutic feature. Zeitschrift für Orthopadie und ihre Grenzgebiete 122(4): 384-392

Rajka, T.; Schreber, P.; Flechsig, P. 1971: The personality of the physician and the development of the course of the disease in the Schreber case (Paul Flechsig). Orvosi Hetilap 112(20): 1143-1148

Terzaghi, C. 1966: The personality of the professional nurse. Boleettino d'Informazioni Della Consociazione Nazionale Infermiere Professionali E Assistenti Sanitarie Visitatrici 19(10): 17-18

Laurin, C. 1974: The personality of the therapist. L'Union Medicale du Canada 103(11): 1929-1933

Newman, D.E. 1974: The personality of violence conversations with protagonists. Mental Health and Society 1(5-6): 328-344

Csikszentmihalyi, M.; Getzels, J.W. 1973: The personality of young artists: an empirical and theoretical exploration. British Journal of Psychology 64(1): 91-104

Cross, P.G.; Cattell, R.B.; Butcher, H.J. 1967: The personality pattern of creative artists. British Journal of Educational Psychology 37(3): 292-299

McIntosh, J.H.; Nasiry, R.W.; Frydman, M.; Waller, S.L.; Piper, D.W. 1983: The personality pattern of patients with chronic peptic ulcer. a case-control study. Scandinavian Journal of Gastroenterology 18(7): 945-950

Bucher, R.; Ulhoa, M.J. 1984: The personality structure of drug users. Acta Psiquiatrica y Psicologica de America Latina 30(3): 209-219

Riemann, F. 1968: The personality structure of the analyst and its influence on the course of treatment. American Journal of Psychoanalysis 28(1): 69-79

König, K. 1980: The personality structure of the patients with anxiety symptoms. Zeitschrift für Psychosomatische Medizin und Psychoanalyse 26(3): 235-245

Garcia, I. 1968: The personality. Schematic summary of some of the most important types. Adm; Revista de la Asociacion Dental Mexicana 25(1): 75-84 concl

Glaser, R.J.; Peabody, F.W. 1981: The personalization of medical care in a research environment. Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha 44(3): 34

Donovan, H. 1971: The personalized nursing audit. Supervisor Nurse 2(12): 37-41

Harrington, M.S.; Tishk, M.N.; Mayberry, W.E. 1980: The personalized system of instruction: a dental hygiene education approach. Educational Directions for Dental Auxiliaries 5(2): 3-8

Simons, D.G.; Prather, W.; Coombs, F.K. 1965: The personalized telemetry medical monitoring and performance data-gathering system for the 1962 SAM-MATS fatigue study. SAM-TR-65-17. SAM-TR. USAF School of Aerospace Medicine 1965: 1-29

Bonnafé, L. 1967: The personnage of the psychiatrist or metamorphoses. 3. L' Evolution Psychiatrique 32(1): 1-36

Bennett, A.C. 1969: The personnel administrator as a hospital manager. Hospital Topics 47(11): 55-58

Jenkins, R.T. 1969: The personnel crisis: our medical responsibility. Military Medicine 134(5): 322-326

Waehre, K. 1972: The personnel in hospital kitchens. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(26): 1720-1721

Defoug, G. 1965: The personnel of health institutions. Gazette Medicale de France 72(8): 1550-1552

Jiménez Romano, R. 1993: The personnel of the National Health System. A reflection on evolution, current status and future perspectives. Revista de Sanidad E Higiene Publica 67(5): 335-342

Nikolaeva, E.G.; Orlova, A.M. 1995: The personnel of the forensic chemistry departments of bureaus of forensic medical expertise. 2. Sudebno-Meditsinskaia Ekspertiza 38(2): 33-34

Jones, E. 1984: The personnel officer. Nursing Mirror 158(11): 40-42

v Susante, A.J. 1967: The personnel problem is solvable. Tijdschrift Voor Ziekenverpleging 20(17): 593-594

Kaplan, J. 1967: The personnel program in nursing homes. Nursing Homes 16(1): 18-24

Manji, F.; Gelbier, S.; Simmons, S. 1983: The personnel required to treat first-year children at schools in three London boroughs. Community Medicine 5(2): 97-103

Femmer, H.J.; Pennekamp, P. 1982: The personnel situation of physicians in the public health service. Das Offentliche Gesundheitswesen 44(2): 123-124

True, W. 1969: The personnel utilization budget--a practical management tool. Hospital Progress 50(7): 65

Romm, S.; Penrose, C.B. 1982: The persons behind the name: Charles Bingham Penrose. Plastic and Reconstructive Surgery 70(3): 397-399

Möse, J.R.; Fischer, G.; Porta, J. 1972: The persoprtion of tetanus-toxin loaded particles. Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 144(3): 251-259

Fariello, R.G.; Ticku, M.K. 1983: The perspective of GABA replenishment therapy in the epilepsies: a critical evaluation of hopes and concerns. Life Sciences 33(17): 1629-1640

Eisnitz, A.J. 1981: The perspective of the self-representation: some clinical implications. Journal of the American Psychoanalytic Association 29(2): 309-336

Alekseeva, R.S. 1969: The perspectives of improving medical service to the population of Chelyabinsk District. Zdravookhranenie Rossiiskoi Federatsii 13(7): 21-24

Matousek, M.; Roubícek, J.; Volavka, J. 1969: The perspectives of research in psychiatric electroencephalography. I. Methods. Electroencephalography and Clinical Neurophysiology 26(2): 233

Roubícek, J.; Matousek, M.; Volavka, J. 1969: The perspectives of research in psychiatric electroencephalography. II. Clinical. Electroencephalography and Clinical Neurophysiology 26(2): 233

Simpson, D.W. 1969: The persuasive definition, with special reference to alcoholism. Medical Journal of Australia 2(24): 1219-1221

Hays, M.T.; Green, F.A. 1972: The pertechnetate joint scan. I. Timing. Annals of the Rheumatic Diseases 31(4): 272-277

Green, F.A.; Hays, M.T. 1972: The pertechnetate joint scan. II. Clinical correlations. Annals of the Rheumatic Diseases 31(4): 278-281

Werner, B.L. 1985: The perturbation of electron beam dose distributions at medium interfaces. Medical Physics 12(6): 754-763

James, R.C.; Roberts, S.M.; Harbison, R.D. 1983: The perturbation of hepatic glutathione by alpha 2-adrenergic agonists. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 3(4): 303-308

Liebesman, M. 1984: The pertussis controversy. Part one--the problem. Delaware Medical Journal 56(10): 588-589

Brooksaler, F.S. 1971: The pertussis syndrome. Texas Medicine 67(1): 56-61

Geller, R.J. 1984: The pertussis syndrome: a persistent problem. Pediatric Infectious Disease 3(2): 182-186

Nong, A.T.; Werblun, M.N. 1983: The pertussis vaccine. American Family Physician 27(2): 127-128

Hinman, A.R. 1984: The pertussis vaccine controversy. Public Health Reports 99(3): 255-259

Fenichel, G.M. 1983: The pertussis vaccine controversy. The danger of case reports. Archives of Neurology 40(4): 193-194

Winter, S. 1982: The pertussis vaccine debate. Harefuah 102(12): 532-534

Zavitzianos, G. 1982: The perversion of fetishism in women. Psychoanalytic Quarterly 51(3): 405-425

Toupet, M.; Pialoux, P. 1981: The perverted nystagmus. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 98(7-8): 319-338

Vincendeau, J. 1970: The pervincamine. Geriatric applications. Bordeaux Medical 3(6): 1719-1722

Chick, R.P.; Collins, H.R.; Rubin, B.D.; Kerlan, R.K.; Jobe, F.W.; Carter, V.S.; Shields, C.L.; Lombardo, S.J. 1981: The pes anserinus transfer. a long-term follow-up. Journal of Bone and Joint Surgery. American Volume 63(9): 1449-1452

Guyer, G.E. 1973: The pesticide paradox. Federation Proceedings 32(7): 1763-1765

Anisimowicz, Z.; Falicki, Z.; Galuszko, P.; Kozielecka, M.; Szawlowski, K. 1965: Role of the psychoprophylaxis and psychotherapy in the rehabilitation of crippled children. Neurologia Neurochirurgia i Psychiatria Polska 15(6): 837-844

Villares, E.J. 1968: The pesticides problem in Puerto Rico. Ims Industrial Medicine and Surgery 37(7): 518

Levinson, B.M. 1967: The pet and the child's bereavement. Mental Hygiene 51(2): 197-200

Karasic, R. 1983: The pet cat that bit the hand that fed it. Hospital Practice 18(5): 46 48

Antelyes, J. 1974: The pet dog a human sex symbol?. Veterinary Medicine-Small Animal Clinician 69(2): 201-204

Miller, R.M. 1971: The pet population explosion: where do we stand?. Veterinary Medicine-Small Animal Clinician 66(12): 1152 Passim

Grossman, L.I.; Cryer, D.R.; Goldring, E.S.; Marmur, J. 1971: The petite mutation in yeast. 3. Nearest-neighbor analysis of mitochondrial DNA from normal and mutant cells. Journal of Molecular Biology 62(3): 565-575

Goldring, E.S.; Grossman, L.I.; Krupnick, D.; Cryer, D.R.; Marmur, J. 1970: The petite mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide. Journal of Molecular Biology 52(2): 323-335

Lautenschlager, S.; Itin, P.H.; Rufli, T. 1994: The petrified ear. Dermatology 189(4): 435-436

Proctor, B. 1983: The petromastoid canal. Annals of Otology Rhinology and Laryngology 92(6 Pt 1): 640-644

Taylor, S. 1982: The petrous temporal bone (including the cerebellopontine angle). Radiologic Clinics of North America 20(1): 67-86

Carr, A. 1981: Reorganisation--a change for the better?. Nursing Mirror 153(10): 30-31

Grayhack, E.J.; Roberts, J.W. 1982: The phage lambda Q gene product: activity of a transcription antiterminator in vitro. Cell 30(2): 637-648

Luk, K.C.; Mark, K.K. 1980: The phage promoter responsible for the expression of the inserted beta-galactosidase gene in bacteriophage lambda plac5. Molecular and General Genetics: Mgg 178(3): 555-560

Geuther, R. 1969: The phage receptor system of Proteus mirabilis Vi. Zeitschrift für Allgemeine Mikrobiologie 9(4): 265-270

Ganiushkin, V.Ia. 1967: The phage titer increase test in the diagnosis of paratyphoid in pigs. Veterinariia 44(3): 97-98

Apostoli, L.A. 1965: The phage titre rise reaction in experiments with typical and atypical typhoid and dysentery cultures. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 42(9): 120-123

Lobova, Z.A. 1966: The phage types of pathogenic staphylococci isolated from workers food concerns in Karaganda and Balkhash. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 43(7): 139

Trüb, C.L.; Posch, J. 1968: The phage typing of Salmonella typhi and Salmonella paratyphi B in Northrhine-Westphalia during the years 1961 to 1965. Ii. Zeitschrift für Immunitatsforschung Allergie und Klinische Immunologie 135(3): 203-218

Jaworkowsky, L.; Shilevitsch, A.; Priedniece, E.; Grant, H. 1980: The phagocytic activity (ingestion and bactericidal activity) of neutrophil leukocytes in chronic myelosis. Folia Haematologica 107(2): 213-220

Osipova, L.P. 1967: The phagocytic activity and cytochemical properties of lung tissue poly-and mononuclears of white mice following their infection by Mycobacterium tuberculosis. Biulleten' Eksperimental'noi Biologii i Meditsiny 64(12): 63-65

Brandukova, N.A. 1967: The phagocytic activity and metabolism of leukocytes of the peripheral blood in acute periodontitis and osteomyelitis. Stomatologiia 46(2): 55-57

Nikiforov, V.A.; Kudriashova, K.I. 1972: The phagocytic activity and some cytochemical changes in leukocytes in infectious diseases. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(2): 92-94

Gusarov, I.P. 1995: The phagocytic activity and the alkaline and acid phosphatase indices of the neutrophilic leukocytes in patients with stomach cancer treated with 5-fluorouracil and zymosan. Klinicheskaia Laboratornaia Diagnostika 2: 36-37

Frolovskaia, T.I. 1967: The phagocytic activity in acute odontogenous infection. Stomatologiia 46(2): 51-54

Morsi, E.O. 1972: The phagocytic activity of fetal neutrophils. Voprosy Okhrany Materinstva i Detstva 17(1): 24-26

Solov'eva, E.I. 1966: The phagocytic activity of leucocytes in children with B. coli infection. Pediatriia 45(11): 79-81

Ternov, V.I. 1965: The phagocytic activity of neutrophils in the blood of white rats under the chronic action of radioactive calcium-45. Radiobiologiia 5(3): 470-473

Trippestad, A.; Midtvedt, T. 1971: The phagocytic activity of polymorphonuclear leucocytes from germfree and conventional rats. Acta Pathologica et Microbiologica Scandinavica. Section B: Microbiology and Immunology 79(4): 519-522

Miler, I.; Tlaskalová, H.; Mandel, L.; Trávnícek, J. 1968: The phagocytic activity of reticuloendothelial system of newborn precolostral pigs to smooth and rough Escherichia coli. Folia Microbiologica 13(6): 472-481

Zschiesche, W.; Heinecke, H.; Klaus, S. 1967: The phagocytic activity of reticulohistiocytic system and its relationship to experimental amyloidosis in the mouse. Beitrage Zur Pathologischen Anatomie und Zur Allgemeinen Pathologie 135(3): 277-290

Dzhikidze, E.K.; Kuksova, M.I.; Kosichenko, L.P. 1995: The phagocytic activity of the blood neutrophils in monkeys undergoing multiple irradiation. Radiatsionnaia Biologiia Radioecologiia 35(2): 250-254

Magliulo, E.; Carcò, F.P.; Cerra, E.; Dionisi, D. 1969: The phagocytic activity of the reticuloendothelial system for colloidal carbon in rats undergoing a treatment with vitamin B complex, with cyanocobalamin, with hydroxycobalamin and with cobamamide. Rivista di Emoterapia Ed Immunoematologia 16(1): 81-88

Flemming, K.; Flemming, C.; Nothdurft, W. 1970: The phagocytic activity of the reticuloendothelial system of mice following whole-body x-irradiation. Journal of the Reticuloendothelial Society 7(1): 1-14

Rohen, J.W.; van der Zypen, E. 1968: The phagocytic activity of the trabecularmeshwork endothelium. An electron-microscopic study of the vervet (Cercopithecus aethiops). Graefe's Archive for Clinical and Experimental Ophthalmology 175(2): 143-160

Latkovic, S.; Nilsson, S.E. 1984: The phagocytic capability of the various zones of the guinea pig conjunctival epithelium: an electron microscopic study. Acta Ophthalmologica 62(3): 453-460

Stamatović, S.M. 1966: The phagocytic capacity of neutrophilic granulocytes from the blood of normal and diseased cattle with special reference to leukosis. Zentralblatt für Veterinarmedizin. Reihe a 13(6): 487-500

Lázár, G.; Biliczki, F.; Kovács, K. 1968: The phagocytic function of the reticuloendothelial system in rats treated with Polybrene, Liquoid and compound 48/80. Pharmacology 1(4): 253-262

Mottaz, J.H.; Zelickson, A.S. 1970: The phagocytic nature of the keratinocyte in human epidermis after tape stripping. Journal of Investigative Dermatology 54(4): 272-278

Mulnard, J.G. 1967: The phagocytic proterties of the trophoblast during the first phases of ovo-implantation in mice. Archives de Biologie 78(4): 575-594

Klemparskaia, N.N.; Dobronravova, N.N.; L'vitsyna, G.M. 1969: The phagocytic reaction as a test detecting the damaging effect of antigen-antibody reactions. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 46(9): 105-109

Kuznetsov, V.F.; Davidov, M.I.; Obernebesova, T.P. 1995: The phagocytic test in the assessment of antimicrobial protection in inflammatory urologic diseases. Urologiia i Nefrologiia 1: 16-18

Huber, H.; Fudenberg, H.H. 1969: The phagocytosis of erythrocyte-antibody complexes in vitro. Blut 19(6): 357-364

Konopka, T.; Zietek, M. 1995: The phagocytosis of polymorphonuclear neutrophilic granulocytes in progressive periodontitis. Schweizer Monatsschrift für Zahnmedizin 105(9): 1129-1133

Stabinsky, Y.; Gottlieb, P.; Fridkin, M. 1980: The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships. Molecular and Cellular Biochemistry 30(3): 165-170

Rasche, B.; May, G.; Ulmer, W.T. 1967: The phagocytotic activity of permanent fibroblasts (monocytes), rat alveolar macrophages and hhuman inflammation macrophages as influenced by glucocorticoids. Zeitschrift für die Gesamte Experimentelle Medizin Einschliesslich Experimentelle Chirurgie 144(4): 335-352

Rasche, B.; Ulmer, W.T. 1970: The phagocytotic activity of permanent fibrocytes (strain L 929) under the effect of glucocorticoides (prednisolon) in dependence of concentration and time after application. Zeitschrift für Zellforschung und mikroskopische Anatomie 105(1): 123-136

Feeney, L. 1973: The phagolysosomal system of the pigment epithelium. a key to retinal disease. Investigative Ophthalmology 12(9): 635-638

Vidal, B.; Candia, C.; Carollo, C. 1980: The phalanges. Notes on the radiographic semeiology of osseous metabolism. Minerva Medica 71(6): 411-418

Gillibert, J. 1972: The phallic blow. Revue Francaise de Psychanalyse 36(2): 301-306

Mayer, E.L. 1995: The phallic castration complex and primary femininity: paired developmental lines toward female gender identity. Journal of the American Psychoanalytic Association 43(1): 17-38

Radomisli, M. 1967: The phallic phase and debasement in the sphere of love. Psychoanalytic Review 54(3): 5-20

Bak, R.C. 1968: The phallic woman: The ubiquitous fantasy in perversions. Psychoanalytic Study of the Child 23: 15-36

Solms, H. 1967: The phantasmic delerious world of a schizophrenic expressed by drawing and modeling before and during psychotherapy. Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 99(1): 168-171

Pazat, P.; Grateau, P. 1970: The phantom hearing (acouphene) after amputation of auditory field by sound trauma. Revue d'Oto-Neuro-Ophtalmologie 42(2): 81-90

Giaquinto, S. 1966: The phantom limb. Rassegna di Neuropsichiatria E Scienze Affini 20(2): 252-271

Scotti, G. 1969: The phantom limb phenomenon secondary to a brachial plexus injury, without amputation. Review of literature and case description. Rivista di Patologia Nervosa E Mentale 90(1): 59-68

Chambry, L. 1964: The phantom limb syndrome in amputees. Atti Della Accademia Dei Fisiocritici in Siena. Sezione Medico-Fisica 13(1): 604-610

Abramson, A.S.; Feibel, A. 1981: The phantom phenomenon: its use and disuse. Bulletin of the new York Academy of Medicine 57(2): 99-112

Iakubov, M.I. 1965: The pharmaceutic service of the population in Tadzhikistan. Aptechnoe Delo 14(5): 70-72

Gheorghiu, E. 1981: The pharmaceutical ancillary staff, an important factor in the field of health education. Viata Medicala; Revista de Informare Profesionala Si Stiintifica A Cadrelor Medii Sanitare 29(9): 209-211

Stüber, W.; Mutschler, E.; Steinbach, D. 1982: The pharmaceutical and biological availability of commercial preparations of furosemide. Arzneimittel-Forschung 32(6): 693-697

Walker, E. 1968: The pharmaceutical consultant. Nursing Homes 17(4): 17-19

Hamarneh, S. 1966: The pharmaceutical exhibition at the Smithsonian. American Journal of Hospital Pharmacy 23(11): 604-609

Burger, H.; Egberink, J.; Lakeman, J. 1980: The pharmaceutical formulation of ORG NC 45. British Journal of Anaesthesia 52(Suppl 1): 7s-8s

Randhawa, J.; Onyshchenko, M. 2019: Acute encephalopathy secondary to dabrafenib and trametinib in BRAF-positive metastatic adenocarcinoma of the lung. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 25(6): 1497-1499

Burrell, C.D. 1981: The pharmaceutical industry. New Zealand Medical Journal 94(689): 111-113

Gray, C. 1981: The pharmaceutical industry -- will Canada become a major research centre?. Canadian Medical Association Journal 124(7): 910; 914

Palkoska, J. 1966: The pharmaceutical industry in 1965. Ceskoslovenska Farmacie 15(4): 177-179

Clavijo, A.R. 1966: The pharmaceutical industry in Colombia. Antioquia Medica 16(2): 95-96

Kaiser, W.; Piechocki, W. 1969: The pharmaceutical industry of Halle during the second half of the 19th century. Münchener Medizinische Wochenschrift 111(40): 2043-2051

Kaiser, W.; Piechocki, W. 1968: The pharmaceutical industry of Halle in the 2nd half of the 18th century. Münchener Medizinische Wochenschrift 110(7): 420-430

Kaiser, W.; Piechocki, W. 1968: The pharmaceutical industry of Halle in the years 1800 to 1850. Münchener Medizinische Wochenschrift 110(49): 2877-2886

Barnes, N.G. 1984: The pharmaceutical industry's experiment with a consumer advisory panel: an inside view. Health Care Management Review 9(4): 7-10

Soyer, R.; Rioux, C.; Dubost, C. 1971: A new technic for the suppression of Pott's anastomosis. La Presse Medicale 79(37): 1649-1650

Woods, D. 1983: The pharmaceutical industry: a prescription. Canadian Medical Association Journal 129(7): 675

Murray, M.J. 1974: The pharmaceutical industry: a study in corporate power. International Journal of Health Services: Planning Administration Evaluation 4(4): 625-640

Gray, C. 1981: The pharmaceutical industry: promoting research in the '80s. Canadian Medical Association Journal 124(6): 787-792 Contd

Peart, W.S. 1980: The pharmaceutical industry: research and responsibility. Lancet 2(8192): 465-466

Cohn, R.E. 1970: The pharmaceutical industry; an easy target. Journal of the American Geriatrics Society 18(5): 387-390

van Arkel, C.G. 1973: The pharmaceutical laboratory at Amsterdam University 1882-1972. Pharmaceutisch Weekblad 108(13): 272-275

Schicke, R.K. 1973: The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons. International Journal of Health Services: Planning Administration Evaluation 3(2): 223-236

Lasagna, L. 1969: The pharmaceutical revolution: its impact on science and society. Science 166(3910): 1227-1233

Moldenhauer, H.; Kala, H.; Zessin, G.; Dittgen, M. 1980: The pharmaceutical technology of tablet making. Physical processes taking place during tablet formation and the effect of pressure on properties of the tablets. Die Pharmazie 35(11): 714-726

Kersley, G.D. 1966: The pharmaceutical treatment of gout. Annals of Physical Medicine 8(6): 199-203

Kline, N.S. 1966: The pharmaceutical treatment of psychiatric patients in general medical practice. Medical Times 94(6): 721-734

Bacon, W.R. 1970: The pharmacism as a health educator. Journal of the American Pharmaceutical Association 10(5): 249-250

Siegmann-Slingerland, W.R. 1968: The pharmacist and Pharmacy Regulations. Pharmaceutisch Weekblad 103(38): 1049-1051

Wilson, R.M. 1969: The pharmacist and Public Law 89-749. Journal of the American Pharmaceutical Association 9(6): 263-265 Passim

Sauvé, F. 1971: The pharmacist and a nutritional intravenous therapy program. American Journal of Hospital Pharmacy 28(2): 106-109

Lamy, P.P.; Kitler, M.E. 1970: The pharmacist and diabetes. Journal of the American Pharmaceutical Association 10(11): 608-618

Kay, I.T.; Punja, N. 1970: The synthesis of potential insecticides. 3. Carbamic esters of 3-cyano-4-hydroxy-thiophens and -pyrroles. Journal of the Chemical Society. Perkin Transactions 17(12): 2409-2412

Diaz Lopez, N. 1971: The pharmacist and first aid in acute poisoning. Revista de Sanidad E Higiene Publica 45(6): 613-638

Smith, M.C. 1972: The pharmacist and generic drugs--a study of ampicillin. Journal of the American Pharmaceutical Association 12(10): 511-515

Arancibia, A. 1974: The pharmacist and his role in the health field. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 76(3): 209-214

Anonymous 1973: The pharmacist and his special knowledge. Lancet 1(7795): 141

Puckett, W.H. 1972: The pharmacist and inhalation therapy. American Journal of Hospital Pharmacy 29(7): 556-563

McGregor, T.D. 1973: The pharmacist and oral health. Journal of the American Pharmaceutical Association 13(5): 238-243

Runge, M.M. 1980: The pharmacist and professional citizenship. American Pharmacy 20(3): 65-66

Chalabala, M. 1965: The pharmacist and society. Ceskoslovenska Farmacie 14(5): 201-202

Smith, M.C.; Tullis, N.; Hopper, C.B. 1969: The pharmacist and the P & T committee. Hospitals 43(24): 82-84

Mason, R. 1973: The pharmacist and the doctor. Nebraska Medical Journal 58(1): 17-20

Ulan, M.S. 1966: The pharmacist and the local hospital. Hospital Management 101(6): 52-58

Terry, L.L. 1970: The pharmacist and the medical care team. American Journal of Pharmacy and the Sciences Supporting Public Health 142(3): 109-115

Hays, D.P. 1982: The pharmacist and the pediatric patient. American Pharmacy 22(1): 22-29

Harderwijk, E.D. 1966: The pharmacist and the pesticide law. Pharmaceutisch Weekblad 101(3): 67-68

de Haen, P. 1971: The pharmacist and the physician. Journal of the American Pharmaceutical Association 11(4): 154-157

Frisz, M.B. 1968: The pharmacist and the small hospital. Hospital Management 105(4): 46; 49

Sceusa, N.A.; Vukovich, R.A.; Bolton, S.; Matoren, G.; Neiss, E.S. 1981: The pharmacist as a drug research monitor. American Pharmacy 21(4): 44-46

Rich, D.S.; Wartman, S.A.; Jeffrey, L.P.; Fulton, J.P. 1983: The pharmacist as a faculty member of a primary care residency program in general internal medicine. American Pharmacy 23(8): 23-27

Ludwig, D.J.; Abramowitz, P.W. 1983: The pharmacist as a member of the CPR team: evaluation by other health professionals. Drug Intelligence and Clinical Pharmacy 17(6): 463-465

Cain, R.M.; Kahn, J.S. 1971: The pharmacist as a member of the health team. American Journal of Public Health 61(11): 2223-2228

Robinson, J.D.; Stewart, R.B.; Curry, R.W. 1982: The pharmacist as a member of the primary care team: experience in a university-based program. Postgraduate Medicine 71(1): 97-103

Provost, G.P. 1971: The pharmacist as a primary practitioner: a guarded view. American Journal of Hospital Pharmacy 28(4): 238-239

Campbell, R.K. 1981: The pharmacist as a resource. Diabetes Educator 7(3): 30-31

Kohlstaedt, E. 1969: The pharmacist as an informant and adviser. Die Medizinische Welt 21: 1259-1261

Knapp, D.E.; Knapp, D.A.; Edwards, J.D. 1969: The pharmacist as perceived by physicians, patrons and other pharmacists. Journal of the American Pharmaceutical Association 9(2): 80

Stimmel, G.L.; McGhan, W.F. 1981: The pharmacist as prescriber of drug therapy: the USC pilot project. Drug Intelligence and Clinical Pharmacy 15(9): 665-672

Sandusky, R.M. 1973: The pharmacist as staff educator and consultant. Hospital and Community Psychiatry 24(12): 844-845

Braun, J. 1984: The pharmacist faces the future: the evolution of North American pharmacy, a utopia or a source of inspiration. Journal de Pharmacie de Belgique 39(5): 285-291

Verain, A. 1984: The pharmacist facing his future. Journal de Pharmacie de Belgique 39(3): 147-158

Halmai, J.; Scheele, C.W. 1966: The pharmacist from Köping (Carl Wilhelm Scheele). Orvosi Hetilap 107(47): 2240-2243

Weart, C.W. 1983: The pharmacist in a family medicine setting. American Pharmacy 23(5): 29-31

Ericson, A.J.; Shainfeld, F.J. 1973: The pharmacist in an obstetrical service. American Journal of Hospital Pharmacy 30(8): 702-704

Verhulst, H.L.; Crotty, J.J.; Maisel, G. 1966: The pharmacist in poison prevention. Journal of the American Pharmaceutical Association 6(1): 17-19

Szczepski, O.; Wlodarczak, K.; Walczak, M.; Walter, Z.; Klauziński, R. 1970: Immunoglobulin level in the saliva of children with poliomyelitis and healthy children following oral vaccination with live attenuatea strain of type 2 and 3 poliovirus. Polski Tygodnik Lekarski 25(8): 281-283

Ivey, M.F. 1973: The pharmacist in the care of ambulatory mental health patients. American Journal of Hospital Pharmacy 30(7): 599-602

Levine, M.E. 1968: The pharmacist in the clinical setting--a nurse's viewpoint. American Journal of Hospital Pharmacy 25(4): 168-171

Soucy, G. 1970: The pharmacist in the hospital. L' Infirmiere Canadienne 12(8): 32-33

Johnson, R.E.; Campbell, W.H.; Christensen, D.B. 1974: The pharmacist in "organized" health care. Hospitals 48(10): 108-112

Bernzweig, E.P. 1968: The pharmacist of the future: a lawyer's view. Journal of the American Pharmaceutical Association 8(11): 591-7 passim

Lane, M.M. 1972: Care of the diabetic in the nursing home. Nursing Homes 21(5): 19-20

Berman, R.S. 1972: The pharmacist on your health care team. Kickbacks vs. legitimate discounts. Nursing Homes 21(12): 12-13

Ellis, E.F. 1973: The pharmacist on your health care team. the pharmacist's role in home health care. Nursing Homes 22(1): 12 Passim

Kratz, A.M. 1973: The pharmacist on your health care team. use of the team approach in medical management. Nursing Homes 22(7): 16-17 Passim

Machbitz, J.M. 1972: The pharmacist on your health team. a meaningful pharmacy policy and procedures manual. Nursing Homes 21(10): 12 Passim

Kempler, K. 1974: The pharmacist strike at Budapest, 1914. Orvosi Hetilap 115(28): 1658-1663

Girstenbrey, W. 1982: The pharmacist's dilemma. Die Medizinische Welt 33(34): 3

Oslet, J. 1971: The pharmacist's documentation. International aspects. Journal de Pharmacie de Belgique 26(6): 681-696

Landis, R.H.; Henley, A.J. 1969: The pharmacist's involvement ... partnership for health. Journal of the American Pharmaceutical Association 9(6): 257-260

Eckel, F.M. 1966: The pharmacist's key to the nursing home: in-service training. Nursing Homes 15(5): 32-36

Rumel, M.J.; Stringfellow, L.C.; Pion, R.J. 1971: The pharmacist's neglected role. Family Planning Perspectives 3(4): 80-82

Owyang, E.; Miller, R.A.; Brodie, D.C. 1968: The pharmacist's new role in institutional patient care. American Journal of Hospital Pharmacy 25(11): 624-630

Trinca, C.E. 1995: The pharmacist's progress toward implementing pharmaceutical care. American Pharmacy 35: 13-18

Cardoni, A.A.; Pierpaoli, P.G. 1974: The pharmacist's responsibility in controlling nosocomial infections. American Journal of Hospital Pharmacy 31(9): 839-843

Miller, L.C. 1970: How good are our drugs?. American Journal of Hospital Pharmacy 27(5): 367-374

Nanda, R.; Baveja, U.; Anand, B.S. 1984: Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet 2(8398): 301-303

McKenney, J.H.; Rabin, D.L.; Heltzer, N.E. 1983: The pharmacist's role in community preventive health care. American Pharmacy 23(8): 16-22

Carabillo, E.A. 1970: The pharmacist's role in drug abuse control. Hospital Progress 51(3): 30-31

Stein, M.H. 1973: The pharmacist's role in home health care. American Journal of Pharmacy and the Sciences Supporting Public Health 145(4): 146-147

Ellis, E.F. 1973: The pharmacist's role in home health care. 2. Nursing Homes 22(2): 15-16

Jinks, M.; Cornely, P.B.; Mayer, F.S. 1983: The pharmacist's role in individual preventive health care. American Pharmacy 23(7): 10-17

Greiner, G.E. 1972: The pharmacist's role in patient discharge planning. American Journal of Hospital Pharmacy 29(1): 72-76

Steiner, H.; Baumgartl, E. 1971: Surgical treatment of hyperthyroidism. Wiener Medizinische Wochenschrift 121(36): 626-629

Barnett, M.; Barletta, F. 1967: The pharmacist's role in radiological health. American Journal of Hospital Pharmacy 24(7): 361-366

Manasse, H.R.; Charney, E.; Emswiller, C.F. 1983: The pharmacist's role in referral. American Pharmacy 23(12): 24-28

Ritchie, E.M.; Harrison, W.L. 1968: The pharmacist's role in the efficient utilization of manpower. Hospital Management 106(1): 70-76

Ritchie, E.M.; Harrison, W.L. 1968: The pharmacist's role in the efficient utilization of manpower. 2. use of management tools. Hospital Management 106(2): 64-67 Passim

Miller, B.M. 1972: The pharmacist's role in the health-care team. Pharmacy is integrant to health care. Australasian Nurses Journal 2(18): 10-11

Dunphy, T.W. 1969: The pharmacist's role in the prevention of adverse drug interactions. American Journal of Hospital Pharmacy 26(7): 366-377

Oderda, G.M.; Litovitz, T.; Verhulst, H.L. 1984: The pharmacist's role in toxicology. American Pharmacy 24(2): 40-44

Ronshagen, J. 1995: The pharmacist's role on the hospital patient management team. American Pharmacy 35(9): 54-59; Quiz 59-60

Taylor, R.S. 1981: The pharmacist's tasks. Medical Journal of Australia 2(2): 107

Fink, J.L. 1982: The pharmacist, the law and veterinary drugs. A brief review. American Pharmacy 22(6): 17-18

Covington, T.R.; Pfeiffer, F.G. 1972: The pharmacist-acquired medication history. American Journal of Hospital Pharmacy 29(8): 692-695

Roberts, C. 1980: The pharmacists primer on price discrimination. American Pharmacy 20(10): 32-37

Whitfield, M. 1968: The pharmacists' contribution to medical care. Practitioner 200(197): 434-438

Mungiu, O.C. 1981: The pharmaco-biochemical basis of the use of glucocorticoids in endotoxic shock. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 85(1): 35-39

Giroud, J.P.; Spector, W.G.; Timsit, J.; Willoughby, D.A. 1973: The pharmaco-cellular assessment of slow acting anti-inflammatory agents. Agents and Actions 3(4): 205-209

Farinet, G.; Piasco, D. 1969: The pharmaco-dynamic test with metoclopramide in the radiological study of pyloric stenosis and of the gastroenteroanastomized stomach. Minerva Radiologica 14(12): 529-543

Dunn, C.R.; Berk, R.N. 1972: The pharmaco-kinetics of telepaque metabolism: the relation of blood concentration and bile flow to the rate of hepatic excretion. American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine 114(4): 758-766

Crainicianu, A. 1971: The pharmacodynamic action of caffeine. Deductions in clinical obstetrics. Minerva Ginecologica 23(23): 984-989

Kraupp, O. 1968: The pharmacodynamic activity spectrum of beta-receptor blocking agents. Wiener Medizinische Wochenschrift 118(36): 696-699

Stojtschew, N.; Hristowa, A. 1966: The pharmacodynamic and nutritive influences on immunological processes in man. Zeitschrift für Immunitatsforschung Allergie und Klinische Immunologie 131(3): 281-293

La Barre, J. 1966: The pharmacodynamic bases of applied therapeutics. Bruxelles Medical 46(18): 463-472

Falkner, B.; Lowenthal, D.T.; Affrime, M.B. 1982: The pharmacodynamic effectiveness of metoprolol in adolescent hypertension. Pediatric Pharmacology 2(1): 49-55

Hill, R.C.; Foote, R.W.; Roemer, D. 1981: The pharmacodynamic properties of fluproquazone. Arzneimittel-Forschung 31(5a): 873-882

Aurousseau, M. 1965: The pharmacodynamic selection of medicaments. Produits and Problemes Pharmaceutiques 20(9): 383-407

Davidson, I.W.; Rollins, F.O.; DiCarlo, F.J.; Miller, H.S. 1971: The pharmacodynamics and biotransformation of pentaerythritol trinitrate in man. Clinical Pharmacology and Therapeutics 12(6): 972-981

Parker, C.J.; Hunter, J.M. 1995: The pharmacodynamics and pharmacokinetics of alcuronium. Anesthesia and Analgesia 81(6): 1315-1316

Serlin, M.J.; Orme, M.L.; MacIver, M.; Green, G.J.; Sibeon, R.G.; Breckenridge, A.M. 1983: The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension. British Journal of Clinical Pharmacology 15(5): 519-527

Laborie, F.; Laborie, F. 1967: The pharmacodynamics of acetylsalicylic acid (aspirin) and its therapeutic value in human medicine and experimental animal study. Dermatologia Internationalis 6(3): 178-187

Grebow, P.; Feeney, W.; Johnston, M.; Lettieri, J.; Li, H.; Magnien, E.; O'Brien, P.; Swillo, R.; Weinryb, I.; Wolf, P.; Marsiglia, J.C. 1981: The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog. Research Communications in Chemical Pathology and Pharmacology 32(3): 407-421

Lewis, D.O. 1974: The pharmacodynamics of depression and its relation to therapy. British Journal of Clinical Practice 28(1): 21-27

Kopel, H.M. 1984: The pharmacodynamics of premedication pedodontic sedative. Cda Journal 12(3): 23-30

Kopel, H.M. 1983: The pharmacodynamics of sedative premedication in pedodontic practice. Acta de Odontologia Pediatrica 4(2): 33-39

O'Reilly, R.A. 1974: The pharmacodynamics of the oral anticoagulant drugs. Progress in Hemostasis and Thrombosis 2(0): 175-213

Marth, W. 1973: The pharmacodynamics of the stimulated bile excretion. Therapie der Gegenwart 112(11): 1752-1754 Passim

Reidenberg, M.M. 1984: The pharmacogenetics of antiarrhythmic drugs. Annals of the new York Academy of Sciences 432: 69-74

Grosch, H. 1967: The pharmacogenic self estrangement of psychotic experiences and possibility of brain functional interpretation. Die Medizinische Welt 10: 569-572

Wang, J.Y. 1981: The pharmacognostical identification of Pseudestellaria heterophylla and its confusions. Zhong Yao Tong Bao 6(3): 8-10

Zhu, Z.Y. 1983: The pharmacognosy and utilization of the resources of Picrasma quassioides. Zhong Yao Tong Bao 8(6): 8-12

Brasseur, T.; Angenot, L. 1984: The pharmacognosy of the passion flower. Journal de Pharmacie de Belgique 39(1): 15-22

Vincent, S.R.; Kimura, H.; McGeer, E.G. 1980: The pharmacohistochemical demonstration of GABA-transaminase. Neuroscience Letters 16(3): 345-348

Grindel, J.M. 1981: The pharmacokinetic and metabolic profile of the antiinflammatory agent tolmetin in laboratory animals and man. Drug Metabolism Reviews 12(2): 363-377

Fuller, R.W.; Collier, J.G. 1983: The pharmacokinetic assessment of sodium cromoglycate. Journal of Pharmacy and Pharmacology 35(5): 289-292

Powell, J.R.; Donn, K.H. 1983: The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications. Journal of Clinical Gastroenterology 5(Suppl 1): 95-113

Cheymol, G.; Biour, M. 1983: The pharmacokinetic basis of of the undesirable effects of drugs in the aged subject. Therapie 38(5): 475-484

Von Hattingberg, H.M.; Brockmeier, D. 1980: The pharmacokinetic basis of optimal antibiotic dosage. Infection Suppl 1: 21-24

Harding, S.M.; Harper, P.B. 1983: The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates. Infection 11(Suppl 1): S49-S53

Hanew, T.; Schenker, S.; Meredith, C.G.; Henderson, G.I. 1984: The pharmacokinetic interaction of diethyl ether with aminopyrine in the rat. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 175(1): 64-69

Revazova, I.A.; Bratslavskiĭ, V.A. 1993: The pharmacokinetic modification of mutagenesis. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 14-19

Shamansurov, S.S. 1994: The pharmacokinetic optimization of depakin in children with epilepsy. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 94(6): 37-38

Bernareggi, A. 1993: The pharmacokinetic profile of nimesulide in healthy volunteers. Drugs 46(Suppl 1): 64-72

Galtier, P.; Alvinerie, M.; Charpenteau, J.L. 1981: The pharmacokinetic profiles of ochratoxin a in pigs, rabbits and chickens. Food and Cosmetics Toxicology 19(6): 735-738

Gugler, R. 1980: The pharmacokinetic properties of beta adrenoceptor blocking drugs. Archives Internationales de Pharmacodynamie et de Therapie Suppl: 27-31

Inoue, A.; Deguchi, T. 1982: The pharmacokinetic studies on spiramycin and acetylspiramycin in rats. Japanese Journal of Antibiotics 35(8): 1998-2004

Taylor, S.H.; Silke, B. 1981: The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure. Annals of the Academy of Medicine Singapore 10(4 Suppl): 45-51

Jones, R.W.; Waugh, A.E.; Woodage, T.J.; Wild, R.N.; Glynne, A. 1980: The pharmacokinetics and acceptability of benoxaprofen following rectal administration. Journal of Rheumatology. Suppl 6: 20-26

Simons, F.E.; Frith, E.M.; Simons, K.J. 1982: The pharmacokinetics and antihistaminic effects of brompheniramine. Journal of Allergy and Clinical Immunology 70(6): 458-464

Simons, F.E.; Simons, K.J.; Frith, E.M. 1984: The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine. Journal of Allergy and Clinical Immunology 73(1 Part 1): 69-75

Houin, G.; Tremblay, D.; Bree, F.; Dufour, A.; Ledudal, P.; Tillement, J.P. 1983: The pharmacokinetics and availability of niflumic acid in humans. International Journal of Clinical Pharmacology Therapy and Toxicology 21(3): 130-134

Zeng, Y.L.; Zhang, Y.D.; Xu, G.Y.; Wang, C.G.; Jiang, J.R. 1984: The pharmacokinetics and bioavailability of O-methyldihydroartemisinine in the rabbits. Yao Xue Xue Bao 19(2): 81-84

Hutt, V.; Pabst, G.; Salama, Z.; Kappler, J.; Jaeger, H. 1995: The pharmacokinetics and bioavailability of a new mexiletine preparation in healthy volunteers. Arzneimittel-Forschung 45(3): 254-257

Dawson, M.; Allan, R.J.; Watson, T.R. 1982: The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole. British Journal of Clinical Pharmacology 14(3): 453-455

Lassman, H.B.; Puri, S.K.; Ho, I.; Sabo, R.; Rosenkilde, H.C. 1984: The pharmacokinetics and bioavailability of nomifensine maleate in healthy men. Journal of Clinical Psychiatry 45(4 Part 2): 26-32

Schran, H.F.; Bitz, D.W.; DiSerio, F.J.; Hirsh, J. 1983: The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination. Thrombosis Research 31(1): 51-67

Hümpel, M.; Krause, W.; Hoyer, G.A.; Wendt, H.; Pommerenke, G. 1984: The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man. European Journal of Drug Metabolism and Pharmacokinetics 9(4): 347-357

Hubbard, J.W.; Hsu, R.S.; Griffiths, L.; Natarajan, C.; Dean, R.; Dileo, E.M.; Hintze, T.H. 1995: The pharmacokinetics and cardiovascular pharmacodynamics of HP 749 (besipirdine HCl) and metabolite P86-7480 in the conscious monkey. Journal of Clinical Pharmacology 35(7): 688-696

Berg, K.J.; Walstad, R.A.; Bergh, K. 1983: The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. British Journal of Clinical Pharmacology 15(3): 347-353

Wright, P.F.; Kaiser, A.B.; Bowman, C.M.; McKee, K.T.; Trujillo, H.; McGee, Z.A. 1981: The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. Journal of Infectious Diseases 143(2): 141-147

Schumann, A.M.; Quast, J.F.; Watanabe, P.G. 1980: The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity. Toxicology and Applied Pharmacology 55(2): 207-219

Stott, W.T.; Quast, J.F.; Watanabe, P.G. 1982: The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. Toxicology and Applied Pharmacology 62(1): 137-151

Ray, J.E.; Wade, D.N. 1982: The pharmacokinetics and metabolism of 14C-carprofen in man. Biopharmaceutics and Drug Disposition 3(1): 29-38

Vollmer, K.O.; Koss, F.W. 1972: The pharmacokinetics and metabolism of a new choleretic, 3-ethyl-4-oxo-5-piperidino- 2, -thiazolidineacetic acid ethyl ester (Piprozolin) after enteral administration in the rat. Archives Internationales de Pharmacodynamie et de Therapie 198(2): 312-332

Ziemniak, J.A.; Wynn, R.J.; Aranda, J.V.; Zarowitz, B.J.; Schentag, J.J. 1984: The pharmacokinetics and metabolism of cimetidine in neonates. Developmental Pharmacology and Therapeutics 7(1): 30-38

Newburger, J.; Castracane, V.D.; Moore, P.H.; Williams, M.C.; Goldzieher, J.W. 1983: The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon. American Journal of Obstetrics and Gynecology 146(1): 80-87

Marcantonio, L.A.; Auld, W.H.; Skellern, G.G.; Howes, C.A.; Murdoch, W.R.; Purohit, R. 1982: The pharmacokinetics and pharmacodynamics of bumetanide in normal subjects. Journal of Pharmacokinetics and Biopharmaceutics 10(4): 393-409

Dunn, G.L.; Morison, D.H.; McChesney, J.; Pine, W.; Kumana, C.R.; Gupta, R.N. 1982: The pharmacokinetics and pharmacodynamics of minaxolone. Journal of Clinical Pharmacology 22(7): 316-320

Asymbekova, G.U.; Banartsev, P.D.; Ochan, T.B.; Rozenfel'd, B.E.; Sariev, A.K.; Folomeeva, I.I.; Pavlovich, S.V. 1995: The pharmacokinetics and pharmacodynamics of prophylactic doses of aspirin in pregnant women from a group at risk for placental insufficiency. Eksperimental'naia i Klinicheskaia Farmakologiia 58(2): 35-39

Park, G.B.; Koss, R.F.; DeFelice, A.F.; O'Neil, S.K.; Edelson, J. 1982: The pharmacokinetics and pharmacodynamics of sulfinalol hydrochloride in dogs after intravenous administration. Archives Internationales de Pharmacodynamie et de Therapie 259(1): 4-13

Marcantonio, L.A.; Auld, W.H.; Murdoch, W.R.; Purohit, R.; Skellern, G.G.; Howes, C.A. 1983: The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease. British Journal of Clinical Pharmacology 15(2): 245-252

Kinney, E.L.; Moskowitz, R.M.; Zelis, R. 1981: The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. Journal of Clinical Pharmacology 21(8-9): 337-342

Klotz, U.; Golbs, E. 1980: The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15889) in rats. Arzneimittel-Forschung 30(4): 619-621

Ziv, G.; Nouws, J.F.; van Ginneken, C.A. 1982: The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. Journal of Veterinary Pharmacology and Therapeutics 5(1): 45-58

Wise, R.; Lockley, R.; Webberly, M.; Adhami, Z.N. 1984: The pharmacokinetics and tissue penetration of enoxacin and norfloxacin. Journal of Antimicrobial ChemoTherapy 14 Suppl C: 75-81

Adhami, Z.N.; Wise, R.; Weston, D.; Crump, B. 1984: The pharmacokinetics and tissue penetration of norfloxacin. Journal of Antimicrobial ChemoTherapy 13(1): 87-92

White, R.A.; Workman, P.; Brown, J.M. 1980: The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole. Radiation Research 84(3): 542-561

Johnson, P.; Griffiths, R.; Lee, R.M.; McDowall, R.D.; Doyle, E.; Taylor, D.C.; Burland, W.L. 1984: The pharmacokinetics in man of SK&F 93319--a new antagonist of histamine H1 and H2 receptors. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 14(7): 589-593

White, R.; Workman, P.; Owen, L. 1982: The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole. International Journal of Radiation Oncology Biology Physics 8(3-4): 473-476

Back, D.J.; Calvey, T.N. 1974: The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles. British Journal of Pharmacology 51(1): 61-65

Sietzen, W. 1982: The pharmacokinetics of 1,000 mg erythromycin lactobionate I. V. in patients with respiratory tract infections. Infection 10(Suppl 2): S99-101

Plevovà, J.; Krebs, V.; Janků, I. 1970: The pharmacokinetics of 6-azauridine administered intravenously in rabbits. Journal de Physiologie 62(Suppl 3): 431-432

Harding, L.K.; Sorgi, M.; Wolverson, R.L.; Mosimann, F.; Sherwin, S.; Donovan, I.A.; Alexander-Williams, J. 1984: The pharmacokinetics of 99mTc HIDA in man and its relationship to intra-gastric bile acids. Scandinavian Journal of Gastroenterology. Suppl 92: 27-29

Wiesner, R.H.; Dickson, E.R.; Carlson, G.L.; McPhaul, L.W.; Go, V.L. 1981: The pharmacokinetics of D-penicillamine in man. Journal of Rheumatology. Suppl 7: 51-55

Okolicsányi, L.; Venuti, M.; Strazzabosco, M.; Iemmolo, R.M.; Nassuato, G.; Orlando, R.; Lirussi, F. 1984: The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis. Acta Physiologica Hungarica 64(3-4): 393-400

Simons, K.J.; Briggs, C.J. 1983: The pharmacokinetics of HI-6 in beagle dogs. Biopharmaceutics and Drug Disposition 4(4): 375-388

Wise, R.; Baker, S.; Wright, N.; Livingston, R. 1980: The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam. Journal of Antimicrobial ChemoTherapy 6(3): 319-322

Erdélyi-Tóth, V.; Csetényi, J.; Kanyár, B.; Kerpel-Fronius, S.; Eckhardt, S. 1981: The pharmacokinetics of N-[14C-formyl]-leurosine in humans. European Journal of Cancer 17(3): 329-335

Back, D.J.; Bolt, H.M.; Breckenridge, A.M.; Crawford, F.E.; Orme, M.L.; Rowe, P.H.; Schindler, A.E. 1980: The pharmacokinetics of a large (3 mg) oral dose of ethynylestradiol in women. Contraception 21(2): 145-153

Segura, J.; García, I.; Borja, L.; Tarrús, E.; Bakke, O.M. 1981: The pharmacokinetics of a new benzamide drug clebopride, in the rat and the dog. Journal of Pharmacy and Pharmacology 33(4): 214-218

Allen, J.G.; Dische, S.; Lenox-Smith, I.; Malcolm, S.L.; Saunders, M.I. 1984: The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans. European Journal of Clinical Pharmacology 27(4): 483-489

Visser, A.A.; Hundt, H.K. 1984: The pharmacokinetics of a single intravenous dose of metronidazole in pregnant patients. Journal of Antimicrobial ChemoTherapy 13(3): 279-283

Gulaid, A.A.; James, I.M.; Kaye, C.M.; Lewellen, O.R.; Roberts, E.; Sankey, M.; Smith, J.; Templeton, R.; Thomas, R.J. 1981: The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.). Biopharmaceutics and Drug Disposition 2(2): 103-114

Cunningham, J.L.; Bullen, M.F.; Evans, D.A. 1974: The pharmacokinetics of acetanilide and of diphenylhydantoin sodium. European Journal of Clinical Pharmacology 7(6): 461-466

Ehninger, G.; Stocker, H.J.; Proksch, B.; Wilms, K. 1980: The pharmacokinetics of adriamycin and adriamycin-metabolites. Klinische Wochenschrift 58(18): 927-934

Martin, E.; Moll, W.; Schmid, P.; Dettli, L. 1984: The pharmacokinetics of alcohol in human breath, venous and arterial blood after oral ingestion. European Journal of Clinical Pharmacology 26(5): 619-626

Bovill, J.G.; Sebel, P.S.; Blackburn, C.L.; Heykants, J. 1982: The pharmacokinetics of alfentanil (R39209): a new opioid analgesic. Anesthesiology 57(6): 439-443

Hull, C.J. 1983: The pharmacokinetics of alfentanil in man. British Journal of Anaesthesia 55(Suppl): 157s-164s

Brode, E.; Hollmann, M.; Vollgraf, C. 1983: The pharmacokinetics of ameziniummetilsulfate in man. Single and repetitive oral administration of a therapeutically effective dose. Arzneimittel-Forschung 33(10): 1491-1497

Foote, E.F.; Look, Z.M.; Giles, P.; Keane, W.F.; Halstenson, C.E. 1995: The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 25(3): 420-425

Höffler, D. 1974: The pharmacokinetics of amoxicillin. Advances in Clinical Pharmacology 7: 28-30

Rauws, A.G.; Olling, M.; Timmerman, A. 1982: The pharmacokinetics of amygdalin. Archives of Toxicology 49(3-4): 311-319

Bailey, R.R.; Eastwood, J.B.; Vaughan, R.B. 1972: The pharmacokinetics of an oral form of carbenicillin in patients with renal failure. Postgraduate Medical Journal 48(561): 422-426

Sharer, W.C.; Fair, W.R. 1982: The pharmacokinetics of antibiotic diffusion in chronic bacterial prostatitis. Prostate 3(2): 139-148

Johnson, C.A.; Zimmerman, S.W.; Rogge, M. 1984: The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 4(1): 3-17

Cerulli, L.; Cimmino, P.T.; Ravagnan, G.P.; Santucci, L.; Bagella, G. 1981: The pharmacokinetics of antibiotics vehicled by soft contact lenses: an experimental approach. Contact and Intraocular Lens Medical Journal 7(1): 39-49

Kawasaki, Y.; Nojima, S. 1982: The pharmacokinetics of antibiotics. II: Distribution of cephalosporins in the oral tissues of rats. Hiroshima Daigaku Shigaku Zasshi. Journal of Hiroshima University Dental Society 14(2): 175-185

Federspil, P. 1982: The pharmacokinetics of azlocillin in the perilymph of guinea pigs and otitis media. Infection 10(Suppl 3): S227-S228

Neu, H.C. 1981: The pharmacokinetics of bacampicillin. Reviews of Infectious Diseases 3(1): 110-116

Preiss, R.; Sohr, R.; Matthias, M.; Brockmann, B.; Hüller, H. 1985: The pharmacokinetics of bendamustine (Cytostasane) in humans. Die Pharmazie 40(11): 782-784

Hamdy, R.C.; Murnane, B.; Perera, N.; Woodcock, K.; Koch, I.M. 1982: The pharmacokinetics of benoxaprofen in elderly subjects. European Journal of Rheumatology and Inflammation 5(2): 69-75

Morgan, D.D.; Warshawsky, D.; Niemeier, R.W.; Bingham, E. 1984: The pharmacokinetics of benzo[alpha]pyrene in the isolated perfused rabbit lung: the influence of benzo[alpha]pyrene, n-dodecane, particulate, or sulfur dioxide. Toxicology 33(3-4): 275-289

Schran, H.F.; Bhuta, S.I.; Schwarz, H.J.; Thorner, M.O. 1980: The pharmacokinetics of bromocriptine in man. Advances in Biochemical Psychopharmacology 23: 125-139

Weston, P.J.; Bourchier, D. 1995: The pharmacokinetics of bupivacaine following interpleural nerve block in infants of very low birthweight. Paediatric Anaesthesia 5(4): 219-222

Davis, J.M.; Janowsky, D.S.; Sekerke, H.J.; Manier, H.; el-Yousef, M.K. 1974: The pharmacokinetics of butaperazine in serum. Advances in Biochemical Psychopharmacology 9(0): 433-443

Mariño, E.L.; Dominguez-Gil, A. 1981: The pharmacokinetics of cefadroxil associated with probenecid. International Journal of Clinical Pharmacology Therapy and Toxicology 19(11): 506-508

Ings, R.M.; Fillastre, J.P.; Godin, M.; Leroy, A.; Humbert, G. 1982: The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. Reviews of Infectious Diseases 4 Suppl: S379-S391

Owen, A.W.; Manson, J.M.; Yates, R.A.; Adshead, V.M.; Houghton, H.L.; Tweedle, D.E. 1983: The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree. Journal of Antimicrobial ChemoTherapy 11 Suppl: 217-221

Höffler, D.; Koeppe, P.; Williams, K.J. 1983: The pharmacokinetics of ceftazidime in normal and impaired renal function. Journal of Antimicrobial ChemoTherapy 12 Suppl A: 241-245

Zong, G.; Xiao, G.; Zhang, Y. 1994: The pharmacokinetics of ceftazidime in the burned patients. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 10(5): 385-388

Kalager, T.; Digranes, A.; Bergan, T.; Solberg, C.O. 1984: The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid. Journal of Antimicrobial ChemoTherapy 13(5): 479-485

Robertson, C.E. 1980: The pharmacokinetics of cefuroxime lysine in the elderly. Methods and Findings in Experimental and Clinical Pharmacology 2(4): 167-169

Peiker, G.; Schröder, S.; Voigt, R.; Müller, B.; Nöschel, H. 1980: The pharmacokinetics of cephalothin during the late stage of pregnancy and in the course of labour. Die Pharmazie 35(12): 790-793

Mulhall, A.; de Louvois, J.; Hurley, R. 1983: The pharmacokinetics of chloramphenicol in the neonate and young infant. Journal of Antimicrobial ChemoTherapy 12(6): 629-639

Tung, C.; Graham, G.G.; Wade, D.N.; Williams, K.M. 1982: The pharmacokinetics of chlorbutol in man. Biopharmaceutics and Drug Disposition 3(4): 371-378

Larsson, R.; Erlanson, P.; Bodemar, G.; Walan, A.; Bertler, A.; Fransson, L.; Norlander, B. 1982: The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. British Journal of Clinical Pharmacology 13(2): 163-170

Yu, H.; Wang, H.Y.; Sun, Z.M. 1994: The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees. Zhonghua Nei Ke Za Zhi 33(7): 449-451

Del Tacca, M.; Ducci, M.; Soldani, G.; Boldrini, A.; Fantoni, M.; Bertelli, A. 1983: The pharmacokinetics of clofoctol in healthy neonates and adults studied by an original HPLC technique. Biological Research in Pregnancy and Perinatology 4(4): 166-168

Duhm, B.; Medenwald, H.; Puetter, J.; Maul, W.; Patzschke, K.; Wegner, L.A. 1974: The pharmacokinetics of clotrimazole 14C. Postgraduate Medical Journal 50(Suppl 1): 13-16

Witten, J.; Frederiksen, P.L.; Mouridsen, H.T. 1980: The pharmacokinetics of cyclophosphamide in man after treatment with allopurinol. Acta Pharmacologica et Toxicologica 46(5): 392-394

Juma, F.D.; Rogers, H.J.; Trounce, J.R. 1980: The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy. British Journal of Clinical Pharmacology 10(4): 327-335

Slevin, M.L.; Piall, E.M.; Aherne, G.W.; Johnston, A.; Lister, T.A. 1982: The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy. Medical and Pediatric Oncology 10(Suppl): 157-168

Alberts, D.S.; Bachur, N.R.; Holtzman, J.L. 1971: The pharmacokinetics of daunomycin in man. Clinical Pharmacology and Therapeutics 12(1): 96-104

Crook, P.R.; Willis, J.V.; Kendall, M.J.; Jack, D.B.; Fowler, P.D. 1982: The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease. European Journal of Clinical Pharmacology 21(4): 331-334

Berman, W.; Musselman, J.; Shortencarrier, R. 1982: The pharmacokinetics of digoxin in newborn and adult sheep. Journal of Pharmacokinetics and Biopharmaceutics 10(2): 173-186

Kanto, J.; Allonen, H.; Kleimola, T.; Mäntylä, R. 1980: The pharmacokinetics of dihydroergotamine in the beagle dog after a single intravenous injection and after a continuous intravenous infusion. Acta Pharmacologica et Toxicologica 46(4): 241-244

Zelis, R.F.; Kinney, E.L. 1982: The pharmacokinetics of diltiazem in healthy American men. American Journal of Cardiology 49(3): 529-532

Aitio, M.L.; Allonen, H.; Kanto, J.; Mäntylä, R. 1982: The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans. International Journal of Clinical Pharmacology Therapy and Toxicology 20(5): 219-226

Jounela, A.J.; Pentikäinen, P.J.; Oksanen, K. 1982: The pharmacokinetics of disopyramide in patients with acute myocardial infarction. International Journal of Clinical Pharmacology Therapy and Toxicology 20(6): 276-282

Harvengt, C.; Desager, J.P. 1982: The pharmacokinetics of dl- and l-moprolol in the human. International Journal of Clinical Pharmacology Therapy and Toxicology 20(2): 57-61

Meredith, P.A.; Elliott, H.L.; McSharry, D.R.; Kelman, A.W.; Reid, J.L. 1983: The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects. British Journal of Clinical Pharmacology 16(1): 27-32

Wohlrab, W.; Wozniak, K.D.; Taube, K.M. 1984: The pharmacokinetics of external skin preparations. Die Pharmazie 39(9): 614-615

Weiss, M.; Sziegoleit, W.; Henschke, E.; von Keyserlingk, G.; Hafemeister, G.; Pönicke, K.; Förster, W. 1980: The pharmacokinetics of falirytmin given orally to humans. Die Pharmazie 35(2): 123

Dowell, P.S.; Pierce, D.M.; Franklin, R.A.; Norris, R.; Harries, H.; Whiteland, H. 1984: The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteers. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 14(12): 947-953

Täuber, U.; Haack, D.; Nieuweboer, B.; Kloss, G.; Vecsei, P.; Wendt, H. 1984: The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. International Journal of Clinical Pharmacology Therapy and Toxicology 22(1): 48-55

Birkeland, J.M.; Lökken, P. 1972: The pharmacokinetics of fluoride in mouth rinses as indicated by a reference substance (51Cr-EDTA). Caries Research 6(4): 325-333

Andreasen, F.; Hansen, U.; Husted, S.E.; Jansen, J.A. 1983: The pharmacokinetics of frusemide are influenced by age. British Journal of Clinical Pharmacology 16(4): 391-397

Hinderling, P.H.; Gundert-Remy, U.; Förster, D.; Gau, W. 1983: The pharmacokinetics of furazlocillin in healthy humans. Journal of Pharmacokinetics and Biopharmaceutics 11(1): 5-30

Federspil, P. 1974: The pharmacokinetics of gentamycin in body fluid and aqueous humors. Arzneimittel-Forschung 24(5): 808-814

Inturrisi, C.E.; Max, M.B.; Foley, K.M.; Schultz, M.; Shin, S.U.; Houde, R.W. 1984: The pharmacokinetics of heroin in patients with chronic pain. New England Journal of Medicine 310(19): 1213-1217

Sundlof, S.F.; Hansen, L.G.; Koritz, G.D.; Sundlof, S.M. 1982: The pharmacokinetics of hexachlorobenzene in male beagles. Distribution, excretion, and pharmacokinetic model. Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(4): 371-381

Blossey, H.C.; Bartsch, H.H.; Kanne, D.; Koebberling, J.; Nagel, G.A. 1982: The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer ChemoTherapy and Pharmacology 8(1): 77-81

Verpooten, G.A.; Verbist, L.; Buntinx, A.P.; Entwistle, L.A.; Jones, K.H.; De Broe, M.E. 1984: The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure. British Journal of Clinical Pharmacology 18(2): 183-193

Sullivan, T.M.; Born, G.S.; Carlson, G.P.; Kessler, W.V. 1983: The pharmacokinetics of inhaled chlorobenzene in the rat. Toxicology and Applied Pharmacology 71(2): 194-203

Kobayashi, T.; Sawano, S.; Itoh, T.; Kosaka, K.; Hirayama, H.; Kasuya, Y. 1983: The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients. Diabetes 32(4): 331-336

Massarella, J.W.; Waller, E.S.; Crout, J.E.; Yakatan, G.J. 1984: The pharmacokinetics of intramuscular gold sodium thiomalate in normal volunteers. Biopharmaceutics and Drug Disposition 5(2): 101-107

Wiesel, F.A.; Alfredsson, G.; Ehrnebo, M.; Sedvall, G. 1980: The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. European Journal of Clinical Pharmacology 17(5): 385-391

Charuel, C.; Nachbaur, J.; Monro, A.M.; De Palol, J. 1981: The pharmacokinetics of intravenous tinidazole in man. Journal of Antimicrobial ChemoTherapy 8(4): 343-344

Bourne, G.R.; Barber, H.E. 1972: The pharmacokinetics of inulin and urea: a comparison of the dose eliminated from a compartmental model and that eliminated in urine. Journal of Pharmacy and Pharmacology 24(7): 532-537

Advenier, C.; Saint-Aubin, A.; Scheinmann, P.; Paupe, J. 1981: The pharmacokinetics of isoniazid in children. Revue Francaise des Maladies Respiratoires 9(5): 365-374

Geĭtman, I.I.; Kivman, G.I.; Kalinina, N.A.; Balyn', I.R. 1973: The pharmacokinetics of kanamycin, including granuloma penetration, in rats treated with chymotrypsin. Antibiotiki 18(11): 1016-1020

Waterman, A.E. 1984: The pharmacokinetics of ketamine administered intravenously in calves and the modifying effect of premedication with xylazine hydrochloride. Journal of Veterinary Pharmacology and Therapeutics 7(2): 125-130

Back, D.J.; Bates, M.; Breckenridge, A.M.; Hall, J.M.; MacIver, M.; Orme, M.L.; Park, B.K.; Rowe, P.H. 1981: The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette. Contraception 23(3): 229-239

Humpel, M.; Toda, T.; Oshino, N.; Pommerenke, G. 1981: The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey. European Journal of Drug Metabolism and Pharmacokinetics 6(3): 207-219

Johnston, A.; Aldhous, M.E.; Hedges, A.; Weerasuriya, K.; Freedman, A.; Turner, P. 1983: The pharmacokinetics of lysine theophylline, a new soluble theophylline, in human volunteers. Postgraduate Medical Journal 59(688): 86-87

Snow, D.H.; Baxter, P.; Whiting, B. 1981: The pharmacokinetics of meclofenamic acid in the horse. Journal of Veterinary Pharmacology and Therapeutics 4(2): 147-156

Woodhouse, K.W.; Hamilton, P.; Lennard, A.; Rawlins, M.D. 1983: The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. European Journal of Clinical Pharmacology 24(2): 283-285

Gilbert, J.D.; Aylott, R.I.; Sögtrop, H.H.; Draffan, G.H. 1984: The pharmacokinetics of meprobamate following its oral and rectal administration as a series of combinations with diphenhydramine, acetylsalicylic acid, codeine and pentaerythritol tetranitrate. Arzneimittel-Forschung 34(10): 1323-1327

Karttunen, P.; Uusitupa, M.; Lamminsivu, U. 1983: The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained-release preparation. International Journal of Clinical Pharmacology Therapy and Toxicology 21(1): 31-36

Skellern, G.G.; Knight, B.I.; Low, C.K.; Alexander, W.D.; McLarty, D.G.; Kalk, W.J. 1980: The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. British Journal of Clinical Pharmacology 9(2): 137-143

Skellern, G.G.; Knight, B.I.; Otter, M.; Low, C.K.; Alexander, W.D. 1980: The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. British Journal of Clinical Pharmacology 9(2): 145-147

Bateman, D.N.; Kahn, C.; Davies, D.S. 1980: The pharmacokinetics of metoclopramide in man with observations in the dog. British Journal of Clinical Pharmacology 9(4): 371-377

Seiler, K.U.; Schuster, K.J.; Meyer, G.J.; Niedermayer, W.; Wassermann, O. 1980: The pharmacokinetics of metoprolol and its metabolites in dialysis patients. Clinical Pharmacokinetics 5(2): 192-198

Welling, P.G.; Monro, A.M. 1972: The pharmacokinetics of metronidazole and tinidazole in man. Arzneimittel-Forschung 22(12): 2128-2132

Mattie, H.; Dijkmans, B.A.; van Gulpen, C. 1982: The pharmacokinetics of metronidazole and tinidazole in patients with mixed aerobic--anaerobic infections. Journal of Antimicrobial ChemoTherapy 10(Suppl): 59-64

Shami, M.; Elliott, H.L.; Kelman, A.W.; Whiting, B. 1983: The pharmacokinetics of mianserin. British Journal of Clinical Pharmacology 15(Suppl 2): 313s-322s

Maguire, K.; McIntyre, I.; Norman, T.; Burrows, G.D. 1983: The pharmacokinetics of mianserin in elderly depressed patients. Psychiatry Research 8(4): 281-287

Vinik, H.R.; Reves, J.G.; Greenblatt, D.J.; Abernethy, D.R.; Smith, L.R. 1983: The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 59(5): 390-394

Smith, M.T.; Eadie, M.J.; Brophy, T.O. 1981: The pharmacokinetics of midazolam in man. European Journal of Clinical Pharmacology 19(4): 271-278

Delwaide, P.A.; Derouaux, G.; Heusghem, C. 1974: The pharmacokinetics of naftazone-3H. Archives Internationales de Pharmacodynamie et de Therapie 208(2): 357-361

Barber, H.E.; Bourne, G.R. 1974: The pharmacokinetics of neostigmine and 3-hydroxyphenyltrimethyl- ammonium in the rat: dose-dependent effects after portal vein administration. British Journal of Pharmacology 52(4): 567-577

Neu, H.C. 1984: The pharmacokinetics of new cephalosporins: significance in clinical practice. Bulletin of the new York Academy of Medicine 60(4): 327-339

Saletu, B.; Grünberger, J.; Linzmayer, L.; Taeuber, K. 1982: The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG. International Pharmacopsychiatry 17(Suppl 1): 43-72

Dawlilng, S.; Lynn, K.; Rosser, R.; Braithwaite, R. 1981: The pharmacokinetics of nortriptyline in patients with chronic renal failure. British Journal of Clinical Pharmacology 12(1): 39-45

Back, D.J.; Breckenridge, A.M.; Crawford, F.E.; Giles, M.; Orme, M.L.; Rowe, P.H. 1981: The pharmacokinetics of oestrone sulphate in the rat. Journal of Steroid Biochemistry 14(10): 1045-1047

Solhaug, J.H.; Bergan, T.; Leinebø, O.; Rosseland, A.R.; Spada, L.; Vaagenes, F. 1984: The pharmacokinetics of one single preoperative dose of metronidazole or tinidazole. Scandinavian Journal of Gastroenterology. Suppl 90: 89-96

Ings, R.M.; Nüdemberg, F.; Burrows, J.L.; Bryce, T.A. 1982: The pharmacokinetics of oxpentifylline in man when administered by constant intravenous infusion. European Journal of Clinical Pharmacology 23(6): 539-543

Bergstrom, R.F.; Kay, R.D.; Wagner, J.G. 1981: The pharmacokinetics of penicillamine in a female mongrel dog. Journal of Pharmacokinetics and Biopharmaceutics 9(5): 603-621

Peiker, G.; Müller, B.; Ihn, W.; Nöschel, H. 1981: The pharmacokinetics of pethidin (Dolcontral) of parturient and their new-borns. Die Pharmazie 36(8): 560-563

Lüllmann, H.; Rossen, E.; Seiler, K.U. 1973: The pharmacokinetics of phentermine and chlorphentermine in chronically treated rats. Journal of Pharmacy and Pharmacology 25(3): 239-243

Droździk, M.; Gawrońska-Szklarz, B.; Wójcicki, J. 1994: The pharmacokinetics of phenytoin in rabbits with hyperlipidemia induced by high-fat diet. Acta Poloniae Pharmaceutica 51(6): 517-519

Sarson, D.L.; Hayter, R.C.; Bloom, S.R. 1982: The pharmacokinetics of porcine glucose-dependent insulinotropic polypeptide (GIP) in man. European Journal of Clinical Investigation 12(6): 457-461

Newell, D.R.; Shepherd, C.R.; Harrap, K.R. 1981: The pharmacokinetics of prednimustine and chlorambucil in the rat. Cancer ChemoTherapy and Pharmacology 6(1): 85-91

Duff, P.; Gibbs, R.S.; Jorgensen, J.H.; Alexander, G. 1982: The pharmacokinetics of prophylactic antibiotics administered by intraoperative irrigation at the time of cesarean section. Obstetrics and Gynecology 60(4): 409-412

Lasek, R.; Wehran, H.J. 1984: The pharmacokinetics of propranolol. Die Pharmazie 39(6): 430-431

Kampmann, J.; Skovsted, L. 1974: The pharmacokinetics of propylthiouracil. Acta Pharmacologica et Toxicologica 35(5): 361-369

Rauws, A.G.; Olling, M.; Timmerman, A. 1982: The pharmacokinetics of prunasin, a metabolite of amygdalin. Journal of Toxicology. Clinical Toxicology 19(8): 851-856

Hicks, R.; Dysken, M.W.; Davis, J.M.; Lesser, J.; Ripeckyj, A.; Lazarus, L. 1981: The pharmacokinetics of psychotropic medication in the elderly: a review. Journal of Clinical Psychiatry 42(10): 374-385

McFadyen, M.L.; Folb, P.I.; Marks, I.N.; Wright, J.P.; Lucke, W. 1981: The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration. Scandinavian Journal of Gastroenterology. Suppl 69: 109-113

McFadyen, M.L.; Folb, P.I.; Miller, R.; Marks, I.N.; Moshal, M.G. 1983: The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration: a comparison of responders and non-responders. European Journal of Clinical Pharmacology 24(4): 441-447

Sweatman, T.W.; Renwick, A.G.; Burgess, C.D. 1981: The pharmacokinetics of saccharin in man. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 11(8): 531-540

Bateman, D.N.; Gokal, R.; Dodd, T.R.; Blain, P.G. 1981: The pharmacokinetics of single doses of metoclopramide in renal failure. European Journal of Clinical Pharmacology 19(6): 437-441

Baggot, J.D.; Love, D.N.; Rose, R.J.; Raus, J. 1981: The pharmacokinetics of some aminoglycoside antibiotics in the horse. Journal of Veterinary Pharmacology and Therapeutics 4(4): 277-284

Slevin, M.L.; Piall, E.M.; Johnston, A.; Levison, D.A.; Aherne, G.W.; Tree, S.B.; Lister, T.A. 1984: The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension. Investigational new Drugs 2(3): 271-276

Slevin, M.L.; Piall, E.M.; Aherne, G.W.; Johnston, A.; Sweatman, M.C.; Lister, T.A. 1981: The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia. British Journal of Clinical Pharmacology 12(4): 507-510

Lindblad, B.; Abisch, E.; Bergqvist, D. 1983: The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion. European Journal of Clinical Pharmacology 24(6): 813-818

Boelaert, J.; Daneels, R.; Schurgers, M.; Lambert, A.M.; Van Landuyt, H.W.; Mellows, G.; Wolf, J.; Swaisland, A.J. 1983: The pharmacokinetics of temocillin in patients with normal and impaired renal function. Journal of Antimicrobial ChemoTherapy 11(4): 349-356

Pullar, T. 1995: The pharmacokinetics of tenidap sodium: introduction. British Journal of Clinical Pharmacology 39(Suppl 1): 1s-2s

Vergin, H.; Strobel, K. 1982: The pharmacokinetics of tetroxoprim in the dog. European Journal of Drug Metabolism and Pharmacokinetics 7(3): 197-202

Manniche, P.M.; Dinneen, L.C.; Langemark, M. 1984: The pharmacokinetics of the individual constituents of an aspirin-metoclopramide combination ('Migravess'). Current Medical Research and Opinion 9(3): 153-156

Jones, M.E.; Nicholas, T.E. 1981: The pharmacokinetics of the intravenous steroid anesthetic alphaxalone in the isolated perfused rat lung. Journal of Pharmacokinetics and Biopharmaceutics 9(3): 343-355

Kurapov, A.P.; Starodubtsev, A.K.; Rubtsova, T.M.; Ignat'ev, V.G.; Kemenova, V.A. 1995: The pharmacokinetics of the new Russian prolonged-action form of diclofenac sodium--Ortopek--in a single oral dose. Eksperimental'naia i Klinicheskaia Farmakologiia 58(1): 53-54

Simons, F.E.; Simons, K.J.; Luciuk, G.H.; Haworth, J.C. 1982: The pharmacokinetics of theophylline in an infant with hepatic failure. Developmental Pharmacology and Therapeutics 4(3-4): 132-138

Bauer, L.A.; Raisys, V.A.; Watts, M.T.; Ballinger, J. 1982: The pharmacokinetics of thiabendazole and its metabolites in an anephric patient undergoing hemodialysis and hemoperfusion. Journal of Clinical Pharmacology 22(5-6): 276-280

Brandon, R.A.; Baggot, J.D. 1981: The pharmacokinetics of thiopentone. Journal of Veterinary Pharmacology and Therapeutics 4(2): 79-85

Safran, M.; Wu, C.F.; Matys, R.; Alex, S.; Emerson, C.H. 1984: The pharmacokinetics of thyrotropin-releasing hormone (TRH) and deamido-TRH in the rat. Endocrinology 115(3): 1031-1037

Sketris, I.S.; Skoutakis, V.A.; Acchiardo, S.R.; Meyer, M.C. 1981: The pharmacokinetics of trichlormethiazide in hypertensive patients with normal and compromised renal function. European Journal of Clinical Pharmacology 20(6): 453-457

Ducci, M.; Scalori, V.; del Tacca, M.; Soldani, G.; Bernardini, C.; Grothe, E.; Bertelli, A. 1981: The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans. International Journal of Clinical Pharmacology Therapy and Toxicology 19(11): 494-497

Ohnhaus, E.E. 1973: The pharmacokinetics of unchanged pindolol in patients with impaired renal function. British Journal of Pharmacology 47(3): 620P-621P

Nitsche, V.; Mascher, H. 1982: The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers. Epilepsia 23(2): 153-162

Van den Berg, H.W.; Desai, Z.R.; Wilson, R.; Kennedy, G.; Bridges, J.M.; Shanks, R.G. 1982: The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination. Cancer ChemoTherapy and Pharmacology 8(2): 215-219

Von Ardenne, M.; Reitnauer, P.G.; Rieger, F. 1967: The pharmacokinetics of vitamin K3-sodium bisulfite as a thermal sensitizer for cancer cells. Archiv für Geschwulstforschung 30(4): 284-306

Garcia-Villar, R.; Toutain, P.L.; Alvinerie, M.; Ruckebusch, Y. 1981: The pharmacokinetics of xylazine hydrochloride: an interspecific study. Journal of Veterinary Pharmacology and Therapeutics 4(2): 87-92

Block, W.; Pingoud, A.; Khan, M.; Kjellerup, P. 1981: The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man. Arzneimittel-Forschung 31(6): 1041-1045

Wood, B.A.; Faulkner, J.K.; Monro, A.M. 1982: The pharmacokinetics, metabolism and tissue distribution of tinidazole. Journal of Antimicrobial ChemoTherapy 10(Suppl): 43-57

Ballard, S.; Shults, T.; Kownacki, A.A.; Blake, J.W.; Tobin, T. 1982: The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse. Journal of Veterinary Pharmacology and Therapeutics 5(1): 21-31

Blackburn, C.H.; Byrne, L.J.; Cullum, V.A.; Farmer, J.B.; Levy, G.P. 1969: The pharmacolgy of 5-(2-t-butylamino-1-hydroxyethyl) salicylamide (ah 3474), a beta-adrenoreceptor blocking agent. Journal of Pharmacy and Pharmacology 21(8): 488-497

Brand, J. 1968: The pharmacologic absis for the control of motion sickness by drugs. Pharmacology for Physicians 2(3): 1-5

Beck, P.S.; Clark, D.G.; Tinston, D.J. 1973: The pharmacologic actions of bromochlorodifluoromethane (BCF). Toxicology and Applied Pharmacology 24(1): 20-29

Khaunina, R.A.; Maslova, M.N. 1968: The pharmacologic activity and cerebral permeability of gamma-aminobutyric acid and its derivatives. Voprosy Psikhiatrii i Nevropatologii; Sbornik Trudov 13: 583-591

Canti, G.; Franco, P.; Nicolin, A. 1983: The pharmacologic activity of 1(2-(p-chloro-alpha-phenylbenzyloxy)ethyl)piperidine (cloperastine). Bollettino Chimico Farmaceutico 122(8): 384-392

Zilov, V.G.; Patyshakuliev, A.P. 1994: The pharmacologic analysis of modulated substance P induced by stimulation of the lateral hypothalamus. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 42-45

Storer, E.H. 1970: The pharmacologic and biochemical nature of carcinoid tumors. Current Problems in Surgery 1970: 41-51

Lillehei, R.C.; Dietzman, R.H.; Motsay, G.J.; Schultz, L.S.; Romero, L.H.; Beckman, C.B. 1972: The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock. Geriatrics 27(7): 73-83

Lillehei, R.C.; Dietzman, R.H.; Motsay, G.J.; Schultz, L.S.; Romero, L.H.; Beckman, C.B. 1972: The pharmacologic approach to the treatment of shock. II. Diagnosis of shock and the plan of treatment. Geriatrics 27(8): 81-94

DeMartino, B.K.; Steinberg, B.J. 1983: The pharmacologic aspects of emergency drugs in dental practice. Compendium of Continuing Education in Dentistry 4(3): 231-236; 238

Pestel, M. 1968: The pharmacologic bases for the medical treatment of arrythmias. La Presse Medicale 76(8): 381-383

McCracken, G.H.; Schaad, U.B. 1982: The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy. Reviews of Infectious Diseases 4 Suppl: S603-S605

Beaver, W.T. 1970: The pharmacologic basis for the choice of an analgesic. I. Potent analgesics. Pharmacology for Physicians 4(10): 1-7

Beaver, W.T. 1970: The pharmacologic basis for the choice of an analgesic. II. Mild analgesics. Pharmacology for Physicians 4(12): 1-7

Hoch, F.L. 1970: The pharmacologic basis for the clinical use of thyroid hormones. Pharmacology for Physicians 4(4): 1-5

Jawetz, E. 1967: The pharmacologic basis for the use of combinations of antimicrobial drugs. Pharmacology for Physicians 1(1): 1-6

Pines, K.L. 1966: The pharmacologic basis for the use of oral hypoglycemic agents in diabetes. Physiology and Pharmacology for Physicians 1(2): 1-5

Soroko, F.E.; Maxwell, R.A. 1983: The pharmacologic basis for therapeutic interest in bupropion. Journal of Clinical Psychiatry 44(5 Part 2): 67-73

Chidsey, C.A.; Gottlieb, T.B. 1974: The pharmacologic basis of antihypertensive therapy: the role of vasodilator drugs. Progress in Cardiovascular Diseases 17(2): 99-113

Wasserman, S.I.; Ramsdell, J.W. 1980: The pharmacologic basis of asthma therapy. Comprehensive Therapy 6(4): 69-75

Preisig, R. 1969: The pharmacologic basis of bronchospasmolytic agents. Respiration; International Review of Thoracic Diseases 26: Suppl: 95-102

Modell, W. 1966: The pharmacologic basis of the use of digitalis in congestive heart failure. Physiology and Pharmacology for Physicians 1(1): 1-6

Bhattacharya, A.N.; Dierschke, D.J.; Yamaji, T.; Knobil, E. 1972: The pharmacologic blockade of the circhoral mode of LH secretion in the ovariectomized rhesus monkey. Endocrinology 90(3): 778-786

Dubovik, B.V.; Shadurskiĭ, K.S.; Etlis, V.S.; Il'iuchenok, T.I.; Frigidova, L.M. 1973: The pharmacologic characteristics of otoline (a histamine liberator of the compound 48-80 type. Farmakologiia i Toksikologiia 36(5): 614-618

Peter, R.H.; Rubin, L. 1984: The pharmacologic control of the pulmonary circulation in pulmonary hypertension. Advances in Internal Medicine 29: 495-520

Kosonen, T. 1966: The pharmacologic dangers of LSD. Suomen Laakarilehti. Finlands Lakartidning 21(21): 1740-1741

Tanabe, M.; Yasuda, D.; LeValley, S.; Mitoma, C. 1969: The pharmacologic effect of deuterium substitution on 5-n-butyl-5-ethylbarbituric acid. Life Sciences 8(19): 1123-1128

Lapaev, E.V.; Udalov, I.F.; Khalatov, O.P. 1971: The pharmacologic effect of pyridoxal, alone and combined with ATP, on the functional state of the vestibular analyzer. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 31(5): 15-19

Winkelstein, A.; Kelley, V.E. 1980: The pharmacologic effects of PGE1 on murine lymphocytes. Blood 55(3): 437-443

Maling, H.M.; Cho, A.K.; Horakova, Z.; Williams, M.A. 1969: The pharmacologic effects of ST-155 (Catapres) and related imidazolines in the rat. Pharmacology 2(6): 337-351

Feun, L.G.; Savaraj, N.; Lu, K.; Guo, Z.; Raulston, L.G.; Benjamin, R.S.; Fields, W.S.; Loo, T.L. 1983: The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles. Journal of Neuro-Oncology 1(3): 219-224

Lu, K.; Loo, T.L. 1980: The pharmacologic fate of the antitumor agent 2-amino-1,3,4-thiadiazole in the dog. Cancer ChemoTherapy and Pharmacology 4(4): 275-279

Olch, A.J.; Silberman, A.W.; Storm, F.K.; Graham, L.S.; Morton, D.L. 1983: The pharmacologic manipulation of blood flow in hyperthermia therapy. Journal of Surgical Oncology 24(4): 292-297

Machover, D. 1994: The pharmacologic modulation of 5-fluorouracil with folinic acid, methotrexate, trimetrexate, and n-phosphonacetyl-l-aspartic acid (PALA). Mechanisms of the interactions and clinical data. Bulletin du Cancer 81(Suppl 2): 74s-77s

Stark, P. 1982: The pharmacologic profile of nabilone: a new antiemetic agent. Cancer Treatment Reviews 9 Suppl B: 11-16

Carlson, R.P.; Dervinis, A.; DiLuigi, J.M.; Capetola, R.J.; Rosenthale, M.E.; Lewis, A.J. 1982: The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent. Arzneimittel-Forschung 32(12): 1546-1553

Mashkovskii, M.D.; Polezhaeva, A.I.; Avrutskii, G.I.; Vertozgadova, O.P.; Smulevich, A.B. 1969: The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 69(8): 1234-1238

Medvedev, B.A. 1973: The pharmacologic properties of beta-(indolinyl-l)ethylguanidine sulfate. Farmakologiia i Toksikologiia 36(5): 530-534

Zakirov, U.B.; Aliev, K.U.; Kamilov, I.K. 1972: The pharmacologic properties of methylapogalanthamine hydrochloride. Farmakologiia i Toksikologiia 35(6): 708-711

Orzechowska, K. 1967: The pharmacologic properties of n-oxide derivatives of methylphenylpiperidine. Archivum Immunologiae et Therapiae Experimentalis 15(2): 290-314

Saratikov, A.S.; Prishchep, T.P.; Stepnova, G.M.; Shmidt, E.V.; Borisova, G.V. 1972: The pharmacologic properties of stearic acid antipyrylamide (stampyrine). Farmakologiia i Toksikologiia 35(6): 723-727

Kuz'mitskiĭ, B.B.; Akhrem, A.A.; Ukhova, L.I.; Marochkin, A.P.; Bludova, G.V. 1972: The pharmacologic properties of stereoisomers of 4-vinylethynyl- and 4-butyl-substituted decahydroquinololes-4. Farmakologiia i Toksikologiia 35(6): 665-668

Cooper, R.W.; Ritota, M.C.; Vincelette, R.B. 1968: The pharmacologic radiocardiogram in health and disease. Angiology 19(4): 203-214

Ein, S.H.; Barker, G.; Olley, P.; Shandling, B.; Simpson, J.S.; Stephens, C.A.; Filler, R.M. 1980: The pharmacologic treatment of newborn diaphragmatic hernia--a 2-year evaluation. Journal of Pediatric Surgery 15(4): 384-394

Guevara, L. 1984: The pharmacologic treatment of portal hypertension. Revista de Gastroenterologia de Mexico 49(4): 207-209

Donaldson, S.R.; Gelenberg, A.J.; Baldessarini, R.J. 1983: The pharmacologic treatment of schizophrenia: a progress report. Schizophrenia Bulletin 9(4): 504-527

Hegner, D.; Lutz, F.; Schischke, B.; Frimmer, M. 1969: The pharmacological action of Cu-chlorophyllin. Naunyn-Schmiedebergs Archiv für Pharmakologie 264(3): 245-246

Shapiro, A.; Ron, M.; Caine, M.; Kramer, J. 1980: The pharmacological action of bromocriptine on the human prostate. Urological Research 8(1): 25-28

Ruffo, A. 1971: The pharmacological action of caffeine. Minerva Medica 62(64): 3026-3027

Odori, Y.; Magee, D.F. 1969: The pharmacological action of gastrin pentapeptide. Experientia 25(2): 169-170

Aström, A. 1966: The pharmacological action of local anesthetics. Acta Anaesthesiologica Scandinavica. Supplementum 25: 19-22

Cao, L.G.; Pei, Y.Q. 1982: The pharmacological actions of 3,4-dichlorophenyl propenoyl isobutylamide on the central nervous system. Yao Xue Xue Bao 17(10): 736-743

Leslie, G.B.; Weetman, D.F. 1969: The pharmacological actions of an experimental acaricide, NC 5016 (5,6-dichloro-1-phenoxycarbonyl-2-trifluoromethyl benzimidazole). Archives Internationales de Pharmacodynamie et de Therapie 177(1): 105-121

Ferrini, R.; Miragoli, G.; Croce, G. 1968: The pharmacological actions of butidrine. a comparative study of this new beta-adrenergic receptor antagonist and its four stereoisomers. Arzneimittel-Forschung 18(7): 829-833

Ranney, B.K.; Fuhrman, F.A.; Schmiegel, J.L.; Mosher, H.S. 1968: The pharmacological actions of some guanidine esters and their relationship to tetrodotoxin. Archives Internationales de Pharmacodynamie et de Therapie 175(1): 193-211

Stvolinskiĭ, S.L.; Kotlobaĭ, A.A.; Boldyrev, A.A. 1995: The pharmacological activity of carnosine. Eksperimental'naia i Klinicheskaia Farmakologiia 58(2): 66-74

Selleri, R.; Orzalesi, G.; Mari, F.; Bertol, E. 1980: The pharmacological activity of different types of alginic acids used for gastric disturbances. Bollettino Chimico Farmaceutico 119(1): 41-51

Niemegeers, C.J.; Leysen, J.E. 1982: The pharmacological and biochemical basis of neuroleptic treatment in schizophrenia. Pharmaceutisch Weekblad. Scientific Edition 4(3): 71-78

Anonymous 1981: The pharmacological and clinical research of a new drug, pyracoine phosphate, for rescuing fulminant cerebral malaria. Zhonghua Nei Ke Za Zhi 20(3): 180-181

Gitlow, S.E. 1970: The pharmacological approach to alcoholism. 1. Maryland State Medical Journal 19(4): 93-96

Gitlow, S.E. 1970: The pharmacological approach to alcoholism. 2. Maryland State Medical Journal 19(5): 103-106

Greaves, M.W. 1969: The pharmacological basis for the rational use of topically applied corticosteroids. Pharmacology for Physicians 3(10): 1-5

Thuillez, C.; Giudicelli, J.F. 1980: The pharmacological basis for the therapeutic utilization of calcium antagonists. Ii. Coeur et Medecine Interne 19(2): 219-226

Flacke, W. 1970: The pharmacological basis for the treatment of myasthenia gravis. Pharmacology for Physicians 4(6): 1-7

Prichard, B.N.; Richards, D.A. 1981: The pharmacological basis for the use of labetalol in the treatment of hypertension. Journal of Cardiovascular Pharmacology 3(Suppl 1): S24-S29

Melville, K.I. 1970: The pharmacological basis of antianginal drugs. Pharmacology for Physicians 4(3): 1-8

Abel, R.M.; Reis, R.L.; Staroscik, R.N. 1970: The pharmacological basis of coronary and systemic vasodilator actions of diazepam (Valium). British Journal of Pharmacology 39(2): 261-274

Aggeler, P.M.; O'Reilly, R.A. 1966: The pharmacological basis of oral anticoagulant therapy. Thrombosis et Diathesis Haemorrhagica. Supplementum 21: 227-256

Dionne, R.A. 1980: The pharmacological basis of pain control in dental practice: analgesics. Compendium on Continuing Education in General Dentistry 1(3): 191-195

Dionne, R.A. 1981: The pharmacological basis of pain control in dental practice: intravenous premedication. Compendium of Continuing Education in Dentistry 2(1): 25-27; 30-31

Dionne, R.A. 1980: The pharmacological basis of pain control in dental practice: local anesthetics. Compendium on Continuing Education in General Dentistry 1(4): 229-233

Dionne, R.A. 1981: The pharmacological basis of pain control in dental practice: nitrous oxide. Compendium of Continuing Education in Dentistry 2(5): 271-274; 276

Boyd, E.M.; Sheppard, E.P.; Boyd, C.E. 1967: The pharmacological basis of the expectorant action of glyceryl guaiacolate. Applied Therapeutics 9(1): 55-59

Vantrappen, G.; Hellemans, J.; Janssens, J. 1967: The pharmacological basis of the treatment of disorders of gastrointestinal motility. Acta Gastro-Enterologica Belgica 30(10): 646-658

Saameli, K. 1972: The pharmacological characterization of beta-sympathicolytic substances. Indian Heart Journal 24(Suppl 1): 146-156

Singh, P.; McDevitt, D.; Mackay, J.; Hadden, D.R. 1973: The pharmacological control of growth hormone release. Studies on the action of L-dopa and chlorpromazine in normal subjects and patients with Parkinsonism, acromegaly and delayed onset of puberty. Journal of Endocrinology 58(1): Xii

Foreman, J.C. 1981: The pharmacological control of immediate hypersensitivity. Annual Review of Pharmacology and Toxicology 21: 63-81

Emadi, M.; Noakes, D.E. 1973: The pharmacological control of the time of parturition in the ewe. Veterinary Record 93(3): 76

Novikov, V.E.; Iasnetsov, V.V. 1994: The pharmacological correction of brain edematous swelling. Eksperimental'naia i Klinicheskaia Farmakologiia 57(6): 65-69

Zabrodskiĭ, P.F. 1994: The pharmacological correction of immune homeostatic disorders in servicemen. Voenno-Meditsinskii Zhurnal 1994(9): 49-52

Novikov, V.E.; Iasnetsov, V.V.; Evseev, A.V.; Merkulova, L.I. 1995: The pharmacological correction of the activity of lipid peroxidation processes in the dynamics of craniocerebral trauma. Eksperimental'naia i Klinicheskaia Farmakologiia 58(1): 46-48

Nelson, D.L.; Mozier, J.O.; White, R.G.; Allen, A.D. 1968: The pharmacological effect of baymix (coumaphos) on poultry. Poultry Science 47(3): 960-962

Lazaratou, H.; Moschovakis, A.; Armaganidis, A.; Kapsambelis, V.; Kiburis, J.; Kephalas, T.A. 1980: The pharmacological effect of fractions obtained by smoking cannabis through a water-pipe. II. a second fractionation step. Experientia 36(12): 1407-1408

Koval', A.P. 1973: The pharmacological effect of reserpine in acute nd chronic pneumonias in children. Pediatriia Akusherstvo i Ginekologiia 1: 15

Yaacob, H.B.; Noor, G.M.; Malek, S.N. 1981: The pharmacological effect of xylocaine topical anaesthetic--a comparison with a placebo. Singapore Dental Journal 6(2): 55-57

Hartmann, S.; Spranger, H. 1983: The pharmacological effect on the intraoral mucosal epithelium of astringents experimental (animal study). Zwr 92(1): 50; 53

Ehrreich, S.J.; Heringslake, J.E.; Warren, F.R.; Weinstock, J.; Tedeschi, R.E. 1969: The pharmacological effects of an unusual hypotensive agent: (SK and F 11197, 2,6-diamino-4-dimethylamino-ethoxy pyrimidine). I. Effects on the cardiovascular system. Archives Internationales de Pharmacodynamie et de Therapie 179(2): 284-302

Altinkurt, O. 1971: The pharmacological effects of extract of Brassica oleracea var. capitata (red cabbage). Turk Hijiyen Ve Tecrubi Biyoloji Dergisi 31(2): 153-158

Doggett, N.S.; Spencer, P.S.; Turner, T.A. 1970: The pharmacological effects of ouabain administered intracerebrally to conscious mice. British Journal of Pharmacology 40(1): 138p-139p

Greenspan, K.; Elizari, M.V. 1974: The pharmacological effects of potassium: the occurrence of sino-ventricular conduction. Journal of Clinical Pharmacology 14(4): 155-162

Sherry, C.J.; Ray, L.E.; Herron, R.E. 1982: The pharmacological effects of the ligroin extract of nutmeg (Myristica fragrans). Journal of Ethnopharmacology 6(1): 61-66

Taeschler, M. 1968: The pharmacological evaluation of drugs. Pharmaceutica Acta Helvetiae 43(9): 540-549

Trendelenburg, U. 1969: The pharmacological importance of the uptake mechanism for sympathomimetic amines. Progress in Brain Research 31: 73-85

Littrell, K.H.; Johnson, C.G.; Schultz, R.E. 1995: The pharmacological management of clozapine-related seizures. Journal of Psychosocial Nursing and Mental Health Services 33(2): 42-43

Murphy, S.; Tyrer, P. 1984: The pharmacological management of depression. International Rehabilitation Medicine 6(2): vi-viii

Papadimitriou, J.M. 1974: The pharmacological mediation of the acute inflammatory response: a brief review. Australasian Journal of Dermatology 15(3): 132-136

Zakusov, V.V. 1971: The pharmacological modifications of synaptic transmission at the level of the encephalon. Actualites Pharmacologiques 24: 211-232

Gilfillan, A.M.; Hollingsworth, M.; Jones, A.W. 1983: The pharmacological modulation of [3H]-disaturated phosphatidylcholine overflow from perifused lung slices of adult rats: a new method for the study of lung surfactant secretion. British Journal of Pharmacology 79(2): 363-371

Ohizumi, Y.; Hikino, H. 1980: The pharmacological nature of asebotoxin III-induced slower phasic contractile response to nerve stimulation in the guinea pig hypogastric nerve-vas deferens. Journal of Pharmacy and Pharmacology 32(3): 224-225

Bell, C. 1969: The pharmacological nature of the response of the reserinized guinea-pig vas deferens to postganglionic nerve stimulation. British Journal of Pharmacology 37(1): 52-56

Sherman, H. 1968: The pharmacological preparation of the apprehensive patient. Journal of Oral Therapeutics and Pharmacology 4(4): 308-314

López Gil, M.; Arribas, F.; Cosío, F.G. 1994: The pharmacological prevention of atrial fibrillation after cardioversion. Revista Espanola de Cardiologia 47(11): 715-718

Durnev, A.D.; Seredenin, S.B. 1993: The pharmacological problems of searching for and using antimutagens. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 19-26

Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity. Arzneimittel-Forschung 33(11): 1555-1569

Paris, J.; Thévenot, R.; Bonnet, P.; Granero, M. 1983: The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative. Arzneimittel-Forschung 33(5): 710-715

Rosell, S.; Björkroth, U.; Xu, J.C.; Folkers, K. 1983: The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Acta Physiologica Scandinavica 117(3): 445-449

Walz, D.T.; DiMartino, M.J.; Griswold, D.E. 1983: The pharmacological profile of auranofin, an orally active gold compound. Scandinavian Journal of Rheumatology. Suppl 51: 16-25

Horie, K.; Hirasawa, A.; Tsujimoto, G. 1994: The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells. European Journal of Pharmacology 268(3): 399-407

Sjögren, C. 1980: The pharmacological profile of lofepramine, a new antidepressant drug. Neuropharmacology 19(12): 1213-1214

Stegmeier, K.; Pill, J.; Müller-Beckmann, B.; Schmidt, F.H.; Witte, E.C.; Wolff, H.P.; Patscheke, H. 1984: The pharmacological profile of the thromboxane A2 antagonist BM 13.177. a new anti-platelet and anti-thrombotic drug. Thrombosis Research 35(4): 379-395

Child, K.J.; Currie, J.P.; Dis, B.; Dodds, M.G.; Pearce, D.R.; Twissell, D.J. 1971: The pharmacological properties in animals of CT1341--a new steroid anaesthetic agent. British Journal of Anaesthesia 43(1): 2-13

Cho, A.K.; Haslett, W.L. 1965: The pharmacological properties of 2,2-bis-(3',4'-dimethoxyphenyl)-N-methyl-N-propargyl ethylamine (BAEA). Life Sciences 4(24): 2411-2416

Duchene-Marullaz, P.; Lakatos, C.; De Marchi, F.; Torrielli, M.V. 1967: The pharmacological properties of 7-chloro-1,3-dihydro-3-hemisuccinyloxy-5-phenyl-2- H-1,4-benzodiazepin-2-one. Il Farmaco; Edizione Pratica 22(9): 506-513

Lachner, O.; Lillie, C.; Rot, A. 1974: The pharmacological properties of Midodrin and its clinical application in patients with hypotensive circulatory disturbance. Wiener Klinische Wochenschrift 86(12): 344-348

Sloboda, A.E.; Tolman, E.L.; Osterberg, A.C.; Panagides, J. 1980: The pharmacological properties of fenbufen. a review. Arzneimittel-Forschung 30(4a): 716-721

Buluk, K.; Malofiejew, M. 1969: The pharmacological properties of fibrinogen degradation products. British Journal of Pharmacology 35(1): 79-89

Adams, S.S.; McCullough, K.F.; Nicholson, J.S. 1969: The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic agent. Archives Internationales de Pharmacodynamie et de Therapie 178(1): 115-129

Nielsen, I.M.; Nymark, M.; Hougs, W.; Pedersen, V. 1966: The pharmacological properties of melitracen (N 7001) and litracen (N 7049). Arzneimittel-Forschung 16(2): 135-140

Berger, F.M.; Bates, H.M.; Diamantis, W.; Kletzkin, M.; Plekss, O.J.; Sofia, R.D.; Spencer, H.J. 1973: The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent. Pharmacology 9(3): 164-176

Kinzirskiĭ, A.S. 1995: The pharmacological protection of the body from malignant tumor metastasis. Voprosy Onkologii 41(2): 46-47

Nayler, W.G. 1980: The pharmacological protection of the ischaemic heart: the use of calcium and beta-adrenoceptor antagonists. European Heart Journal 1(Suppl B): 5-13

Armitage, A.K.; Dean, A.C. 1967: The pharmacological similarity of pylorus and antrum. Gastroenterology 52(1): 136-137

Brezenoff, H.E.; Wirecki, T.S. 1970: The pharmacological specificity of muscarinic receptors in the posterior hypothalamus of the rat. Life Sciences. Pt. 1: Physiology and Pharmacology 9(2): 99-109

Uesaka, I.; Ishiwatari, S. 1970: The pharmacological studies of Sauer Placenta. Zasshi. Tokyo Ika Daigaku 28(2): 226-236

Ishitani, R.; Saito, E.; Kitagawa, H. 1970: The pharmacological studies on dimetacrine. I. Studies on the absorption, distribution and excretion of H3-labeled dimetacrine in the rat. Japanese Journal of Pharmacology 20(3): 432-438

Jiang, Y.; Liu, G.Q.; Ma, J.R.; Xie, L.; Wu, H.Q. 1982: The pharmacological studies on methyl-eugenol. Yao Xue Xue Bao 17(2): 87-92

Shibuya, T.; Kuroda, K. 1969: The pharmacological study of the effect of alpha-(isopropyl) -alpha- (beta-dimethyl aminopropyl) phenylacetonitril cyclamate (Perocan) on the central nervous system. Zasshi. Tokyo Ika Daigaku 27(5): 715-729

Levey, M.; Biklarish, I. 1971: The pharmacological table of ibn Biklãrish. Journal of the History of Medicine and Allied Sciences 26(4): 413-421

Gasanov, U.G.; Martinson, I.L.; Khokhlova, V.N. 1994: The pharmacological testing of intracortical interneuronal connections. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 44(6): 1016-1025

Lazzarin, M.; Segattini, L.; Benati, F. 1993: The pharmacological therapy of Basedow's disease. Recenti Progressi in Medicina 84(10): 698-708

Pérez Jiménez, F. 1995: The pharmacological treatment of hypercholesterolemia. Revista Espanola de Cardiologia 48(Suppl 5): 31-38

Spiker, D.G. 1981: The pharmacological treatment of schizoaffective disorder-depressed: a review of the literature. Psychopharmacology Bulletin 17(1): 75-78

Sandberg, F.; Roos, K.; Ryrberg, K.J.; Kristianson, K. 1969: The pharmacologically active alkaloids of Strychnos icaja Baill: strychnine and a new alkaloid, 4-hydroxystrychnine. Acta Pharmaceutica Suecica 6(1): 103-108

Andersen, V. 1968: The pharmacologist and the hospital. Ugeskrift for Laeger 22: 1942-1944

Dews, P.B. 1970: The pharmacologist's dilemma: when is a drug safe for general consumption?. Pediatrics 45(1): 3-6

Hollister, L.E. 1971: The pharmacologist--clinical investigator dialogue in evaluation of new psychotherapeutic drugs. Journal of Clinical Pharmacology and new Drugs 11(2): 77-82

Desnoyers, P.; Labaume, J.; Anstett, M.; Herrera, M.; Pesquet, J.; Sebastien, J. 1972: The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study. Arzneimittel-Forschung 22(10): 1691-1695

Bickel, M.H. 1969: The pharmacology and biochemistry of N-oxides. Pharmacological Reviews 21(4): 325-355

Wampler, G. 1983: The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25(Suppl 1): 35-51

Fasola, A.F.; Carmichael, R. 1974: The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent. Acta Cardiologica Suppl 18: 317-333

Harrison, D.C.; Alderman, E.L. 1972: The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972. Modern Treatment 9(1): 139-175

Hollander, W.; Wilkins, R.W. 1966: The pharmacology and clinical use of rauwolfia, hydralazine, thiazides, and aldosterone antagonists in arterial hypertension. Progress in Cardiovascular Diseases 8(4): 291-318

Bänder, A. 1971: The pharmacology and metabolism of oral antidiabetic drugs. Australian and New Zealand Journal of Medicine 1(Suppl 2): 22-30

Bray, M.A. 1983: The pharmacology and pathophysiology of leukotriene B4. British Medical Bulletin 39(3): 249-254

Sherrod, T.M. 1966: The pharmacology and physiology of drug addiction. Illinois Medical Journal 130(4): 453-456

Baublitz, F.U. 1966: The pharmacology and rationale of drugs used in the control of glaucoma. American Journal of Optometry and Archives of American Academy of Optometry 43(7): 451-470

Brace, L. 1983: The pharmacology and therapeutics of vitamin K. American Journal of Medical Technology 49(6): 457-463

Nelson, E.B. 1980: The pharmacology and toxicology of meta-substituted acetanilide I: acute toxicity of 3-hydroxyacetanilide in mice. Research Communications in Chemical Pathology and Pharmacology 28(3): 447-456

Dasta, J.F. 1994: The pharmacology column on midazolam. Critical Care Nurse 14(2): 20-21

Beleslin, D.B.; Grabović, L.; Radmanović, B.Z. 1974: The pharmacology fo gross behavioural effects of cholinomimetic substances injected into the cerebral ventricles of unanaesthetized cats: evidence for central muscarinic mediation. Neuropharmacology 13(12): 1163-1169

Chiou, C.Y.; Long, J.P.; Greenberg, S.; Shriver, D.A. 1972: The pharmacology of (4,4'-biphenylene-bis-(2-oxoethylene))-bis-((di-2-ethoxyethyl) methylammonium bromide) "DEO". Archives Internationales de Pharmacodynamie et de Therapie 199(1): 29-42

Harris, L.S.; Pierson, A.K.; Dembinski, J.R.; Dewey, W.L. 1967: The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan). Archives Internationales de Pharmacodynamie et de Therapie 165(1): 112-126

Knoll, J.; Mészáros, Z.; Szentmiklósi, P.; Fürst, S. 1971: The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non narcotic analgesic. I. Some basic correlations between the chemical structure and activity of homopyrimidazol analgesics. Selection of MZ-144. Arzneimittel-Forschung 21(5): 717-719

Knoll, J.; Fürst, S.; Mészáros, Z. 1971: The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. 3. Analysis of the central and peripheric effects. Arzneimittel-Forschung 21(5): 727-733

Knoll, J.; Magyar, K.; Bánfi, D. 1971: The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. IV. the fate of MZ-144 within the organism. Arzneimittel-Forschung 21(5): 733-738

Knoll, J.; Fürst, S.; Mészáros, Z. 1971: The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. II. Toxicity and analgetic effect of MZ-144 compared to narcotic and non-narcotic analgesics. Arzneimittel-Forschung 21(5): 719-727

Glenn, E.M.; Bowman, B.J.; Kooyers, W.; Koslowske, T.; Myers, M.L. 1967: The pharmacology of 2,3-bis-(p-methoxyphenyl)-indole (indoxole). Journal of Pharmacology and Experimental Therapeutics 155(1): 157-166

Glenn, E.M.; Rohloff, N.; Bowman, B.J.; Lyster, S.C. 1973: The pharmacology of 2-(2-fluoro-4-biphenylyl)propionic acid (flurbiprofen). a potent non-steroidal anti-inflammatory drug. Agents and Actions 3(4): 210-216

Chen, G.; Ensor, C.R.; Bohner, B. 1969: The pharmacology of 2-(ethylamino)-2-(2-thienyl)-cyclohexanone-HCl (CI-634). Journal of Pharmacology and Experimental Therapeutics 168(1): 171-179

Zager, R.F.; McCarty, L.P.; Standaert, F.G. 1969: The pharmacology of 2-aziridinyl ethanol. Journal of Pharmacology and Experimental Therapeutics 166(2): 205-216

Ranney, B.K.; Fuhrman, F.A. 1968: The pharmacology of 2-imino-5-benzoyloxy-hexahydropyrimidine. Proceedings of the Western Pharmacology Society 11: 54-56

Suchowsky, G.K.; Pegrassi, L. 1969: The pharmacology of 4H-3-methylcarboxyamide-1,3-benzoxazine-2-one (F.I. 6654), a compound acting on the central nervous system. Arzneimittel-Forschung 19(4): 643-648

Sayers, A.C.; Bürki, H.R.; Eichenberger, E. 1980: The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent. Arzneimittel-Forschung 30(5): 793-803

Thoenen, H.; Tranzer, J.P. 1973: The pharmacology of 6-hydroxydopamine. Annual Review of Pharmacology 13: 169-180

Stille, G.; Lauener, H.; Eichenberger, E. 1971: The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine). Il Farmaco; Edizione Pratica 26(10): 603-625

Brittain, R.T.; Tyers, M.B. 1973: The pharmacology of AH8165: a rapid-acting, short-lasting, competitive neuromuscular blocking drug. British Journal of Anaesthesia 45(8): 837-843

Palfreyman, M.G.; Schechter, P.J.; Buckett, W.R.; Tell, G.P.; Koch-Weser, J. 1981: The pharmacology of GABA-transaminase inhibitors. Biochemical Pharmacology 30(8): 817-824

Stenger, V.G.; Maren, T.H. 1974: The pharmacology of MS 222 (ethyl-m-aminobenzoate) in Squalus acanthias. Comparative and General Pharmacology 5(1): 23-35

Dóda, M.; György, L.; Pfeifer, A.K.; Zára-Kaczián, E.; Fodor, M. 1972: The pharmacology of N, -dimethyl-N- -chloroethylphenethylamine. Hci--effects on the autonomic nervous system. Archives Internationales de Pharmacodynamie et de Therapie 196(2): 280-287

Boura, A.L.; Fitzgerald, A.E. 1966: The pharmacology of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride. a potent and long lasting central depressant. British Journal of Pharmacology and ChemoTherapy 26(2): 307-321

Duhault, J.; Boulanger, M.; Tisserand, F.; Bergi, L. 1972: The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species. Arzneimittel-Forschung 22(10): 1682-1685

Duhault, J.; Lebon, F. 1972: The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats. Arzneimittel-Forschung 22(10): 1686-1690

Ehrreich, S.J.; Heringslake, J.E.; Jablonski, R.; Weinstock, J.; Tedeschi, R.E. 1969: The pharmacology of SK and F 11197 (2,6 diamino-4-dimethylaminoethoxy pyrimidine), an unusual hypotensive agent. II. Mode of action studies. Archives Internationales de Pharmacodynamie et de Therapie 179(2): 303-313

Bilski, A.J.; Halliday, S.E.; Fitzgerald, J.D.; Wale, J.L. 1983: The pharmacology of a beta 2-selective adrenoceptor antagonist (ICi 118,551). Journal of Cardiovascular Pharmacology 5(3): 430-437

Stroman, F.; Jakovlev, V.; Metzenauer, P.; Roth, E.; Thiemer, K. 1984: The pharmacology of a new cardiosteroid, a partially synthetic derivative of the aglycone hellebrigenin (acrihellin). Arzneimittel-Forschung 34(7): 769-779

Kharkhevich, D.A. 1966: The pharmacology of a new nondepolarizing muscle relaxant: cyclobutonium. Farmakologiia i Toksikologiia 29(1): 47-52

Biró, K.; Kárpáti, E. 1981: The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201). Arzneimittel-Forschung 31(11): 1918-1924

Cooper, P. 1967: The pharmacology of addiction. i. Midwife and Health Visitor 3(9): 365-367

Gill, R. 1994: The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovascular and Brain Metabolism Reviews 6(3): 225-256

Shapero, M.; Southgate, P.J. 1970: The pharmacology of ambenoxan (2-(3',6'-dioxaheptyl)-aminomethyl-1:4-benzodioxane), a centrally acting muscle relaxant. British Journal of Pharmacology 38(2): 263-270

Curtis, D.R.; Watkins, J.C. 1965: The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacological Reviews 17(4): 347-391

Norris, S.M.; Ravdin, J.I. 1984: The pharmacology of aminoglycosides--I. Considered as a group. Infection Control: Ic 5(4): 188-191

Geller, R.J.; Norris, S.M. 1984: The pharmacology of aminoglycosides: II. Distinctions among the agents. Infection Control: Ic 5(6): 298-302

Wooster, A.G.; Lockett, M.F.; Curnow, D.H.; Joske, R.A. 1966: The pharmacology of an oral diuretic ("Doburil") in congestive cardiac failure: a comparison with hydrochlorothiazide. Medical Journal of Australia 2(14): 633-635

Nijkamp, F.P. 1984: The pharmacology of anti-asthmatic drugs. Agents and Actions. Supplements 14: 83-103

Casselman, W.G. 1965: The pharmacology of anti-hypertensive drugs. Applied Therapeutics 7(11): 949-953

Dechy, H. 1980: The pharmacology of antibiotics. L' Information Dentaire 62(35): 3084-3091

Alexandre, J.M.; Ménard, J.; Milliez, P. 1973: The pharmacology of antihypertensive agents. La Revue du Praticien 23(9): 651

Christensen, S. 1981: The pharmacology of antihypertensive agents. Sites and mechanisms of action, side effects and contraindications. Ugeskrift for Laeger 143(7): 397-403

Parnham, M.J. 1984: The pharmacology of antirheumatic drugs. Agents and Actions. Supplements 14: 153-169

Hughes, R.; Chapple, D.J. 1981: The pharmacology of atracurium: a new competitive neuromuscular blocking agent. British Journal of Anaesthesia 53(1): 31-44

Tozzi, S.; Roth, F.E.; Tabachnick, I.I. 1974: The pharmacology of azatadine, a potential antiallergy drug. Agents and Actions 4(4): 264-270

Knoll, J.; Fürst, S.; Kelemen, K. 1973: The pharmacology of azidomorphine and azidocodeine. Journal of Pharmacy and Pharmacology 25(12): 929-939

Hogan, P.M.; Albuquerque, E.X. 1971: The pharmacology of batrachotoxin. 3. Effect on the heart Purkinje fibers. Journal of Pharmacology and Experimental Therapeutics 176(3): 529-537

Warnick, J.E.; Albuquerque, E.X.; Sansone, F.M. 1971: The pharmacology of batrachotoxin. I. Effects on the contractile mechanism and on neuromuscular transmission of mammalian skeletal muscle. Journal of Pharmacology and Experimental Therapeutics 176(3): 497-510

Albuquerque, E.X.; Warnick, J.E.; Sansone, F.M. 1971: The pharmacology of batrachotoxin. II. Effect on electrical properties of the mammalian nerve and skeletal muscle membranes. Journal of Pharmacology and Experimental Therapeutics 176(3): 511-528

Albuquerque, E.X.; Warnick, J.E. 1972: The pharmacology of batrachotoxin. IV. Interaction with tetrodotoxin on innervated and chronically denervated rat skeletal muscle. Journal of Pharmacology and Experimental Therapeutics 180(3): 683-697

Albuquerque, E.X.; Warnick, J.E.; Sansone, F.M.; Daly, J. 1973: The pharmacology of batrachotoxin. V. a comparative study of membrane properties and the effect of batrachotoxin on sartorius muscles of the frogs Phyllobates aurotaenia and Rana pipiens. Journal of Pharmacology and Experimental Therapeutics 184(2): 315-329

Jansson, S.E.; Albuquerque, E.X.; Daly, J. 1974: The pharmacology of batrachotoxin. VI. Effects on the mammalian motor nerve terminal. Journal of Pharmacology and Experimental Therapeutics 189(2): 525-537

Dawson, W.; Boot, J.R.; Harvey, J.; Walker, J.R. 1982: The pharmacology of benoxaprofen with particular to effects on lipoxygenase product formation. European Journal of Rheumatology and Inflammation 5(2): 61-68

Banerjee, A.; Aramanadka, R.; Saini, A.G.; Vyas, S. 2018: Acute encephalopathy with biphasic seizures and late diffusion restriction in scrub typhus encephalitis. European Journal of Pediatrics 177(10): 1581-1583

Shanks, R.G. 1966: The pharmacology of beta sympathetic blockade. American Journal of Cardiology 18(3): 308-316

Lucchesi, B.R.; Whitsitt, L.S. 1969: The pharmacology of beta-adrenergic blocking agents. Progress in Cardiovascular Diseases 11(5): 410-430

Adam, Z.; Vorlícek, J.; Tomíska, M. 1994: The pharmacology of biphosphonates and their use in hypercalcemia. Vnitrni Lekarstvi 40(10): 667-670

Raisz, L.G. 1970: The pharmacology of bone. Introduction. Federation Proceedings 29(3): 1176-1178

Scheinberg, P. 1966: The pharmacology of brain blood flow. Research Publications - Association for Research in Nervous and Mental Disease 41: 216-225

Solov'ev, V.N.; Berezhinskaia, V.V.; Bykova, M.A.; Berezina, E.K.; Egorenko, G.G. 1974: The pharmacology of carbenicillin. Antibiotiki 19(5): 439-444

Noack, E. 1971: The pharmacology of cardiac glycosides. Medizinische Klinik 66(16): 583-586

Hayes, A.H. 1972: The pharmacology of cardio-active agents. Cardiovascular Clinics 4(3): 103-118

Gauthier, M.; van Doesburg, N.; Lacroix, J.; Rousseau, E. 1984: The pharmacology of cardiorespiratory resuscitation in children. L'Union Medicale du Canada 113(2): 106-111

Griffith, R.S. 1983: The pharmacology of cephalexin. Postgraduate Medical Journal 59(Suppl 5): 16-27

Cole, A.E.; Nicoll, R.A. 1984: The pharmacology of cholinergic excitatory responses in hippocampal pyramidal cells. Brain Research 305(2): 283-290

Scully, B.E.; Steinman, R.; Chin, N.X.; Neu, H.C. 1984: The pharmacology of clavulanic acid and ticarcillin combined. Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(6): 385-389

Jones, R.T. 1984: The pharmacology of cocaine. Nida Research Monograph 50: 34-53

Kadatz, R. 1970: The pharmacology of coronarotropic drugs using dipyridamole as an example. Bruxelles Medical 50(9): 609-616

Gillette, P.N.; Lu, Y.S.; Peterson, C.M. 1973: The pharmacology of cyanate with a summary of its initial usage in sickle cell disease. Progress in Hematology 8: 181-190

Blum, K.; Seifter, E.; Seifter, J. 1971: The pharmacology of d- and l-carnitine and d- and l-acetylcarnitine. Comparison with choline and acetylcholine. Journal of Pharmacology and Experimental Therapeutics 178(2): 331-338

Egorin, M.J.; Bellis, E.H.; Salcman, M.; Collins, J.M.; Spiegel, J.F.; Bachur, N.R. 1984: The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies. Journal of Neurosurgery 60(5): 1005-1013

Barfknecht, C.F.; Keckler, D.; Long, J.P.; Greenberg, S. 1973: The pharmacology of dibenzofuran and terphenyl derivatives of DMAE and hemicholinium-3. Archives Internationales de Pharmacodynamie et de Therapie 205(2): 238

Litvinchuk, M.D.; Nevelichuk, V.V. 1972: The pharmacology of dimethylsulfoxide. Farmakologiia i Toksikologiia 35(6): 727-731

Leszkovszky, G.; Tardos, L.; Erdély, I.; Harsányi, K. 1966: The pharmacology of diphenylalkyl derivatives. I. Comparative studies of coronary dilator diphenylalkylamine derivatives. Acta Physiologica Academiae Scientiarum Hungaricae 29(3): 283-297

Golikov, S.N.; Shchekoldina, V.I.; Simonova, I.G. 1972: The pharmacology of dipyroxime. Farmakologiia i Toksikologiia 35(5): 589-592

Zung, W.W. 1970: The pharmacology of disordered sleep: a laboratory approach. International Psychiatry Clinics 7(2): 123-146

Leaders, F.E.; Fortenberry, B.R.; Chiang, T.S.; Van Hoose, M.C. 1971: The pharmacology of dl-1-(4-hydroxyphenyl)-2-isopropylamino ethanol hydrochloride, an ocular hypotensive agent in rabbits. Archives Internationales de Pharmacodynamie et de Therapie 190(2): 368-382

Fuller, L.M. 1984: The pharmacology of drinking behavior. Pharmacology and Therapeutics 24(2): 179-206

Russell, I.J. 1971: The pharmacology of efferent synapses in the lateral-line system of Xenopus laevis. Journal of Experimental Biology 54(3): 643-658

Stopp, G.; Niedrich, H. 1967: The pharmacology of eledoisin, physalaemin and their synthetic analogs--an example for the study of structure-effect relationships of peptides. Ii. Zeitschrift für Arztliche Fortbildung 61(7): 359-371

Gorbatova, E.N. 1967: The pharmacology of estocin, an new analgesic. Stomatologiia 46(2): 22-25

Newbould, B.B. 1969: The pharmacology of fenclozic acid (2-(4-chlorophenyl)-thiazol-4-ylacetic acid; I.C.I. 54,450; 'Myalex'); a new compound with anti-inflammatory, analgesic and antipyretic activityl. British Journal of Pharmacology 35(3): 487-497

Barnett, A.; Goldstein, J.; Fiedler, E.P.; Taber, R.I. 1974: The pharmacology of fletazepam a centrally-acting muscle relaxant. Archives Internationales de Pharmacodynamie et de Therapie 212(1): 164-174

Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H.; Lenaerts, F.M.; Verbruggen, F.J.; van Nueten, J.M.; Marsboom, R.H.; Hérin, V.V.; Schaper, W.K. 1970: The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug. Arzneimittel-Forschung 20(11): 1689-1698

Au, J.L.; Sadée, W. 1981: The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 76: 100-114

Puls, W.; Losert, W.; Loge, O.; Schillinger, E.; Keup, U.; Kroneberg, G. 1974: The pharmacology of glisoxepide, a new oral antidiabetic. Arzneimittel-Forschung 24: 375-392

Juan, H. 1984: The pharmacology of gold compounds. Wiener Klinische Wochenschrift. Supplementum 156: 7-13

Tothill, A. 1980: The pharmacology of gynaecology. Practitioner 224(1347): 887-890

Janssen, P.A. 1967: The pharmacology of haloperidol. International Journal of Neuropsychiatry 3(Suppl 1): 10-18

Wilkinson, M. 1982: The pharmacology of headache. Panminerva Medica 24(2): 95-97

Houghton, J.; Phillips, E.M. 1973: The pharmacology of human isolated pulmonary vascular tissue. British Journal of Pharmacology 47(3): 676P-677P

Gyermek, L. 1966: The pharmacology of imipramine and related antidepressants. International Review of Neurobiology 9: 95-143

Levy, L. 1966: The pharmacology of immunosuppressant drugs and experimental models. Survey of Ophthalmology 11(4): 444-453

Mitchell, M.S.; Bertino, J.R. 1970: The pharmacology of immunosuppressive agents. Connecticut Medicine 34(12): 843-850

Santos, G.W. 1968: The pharmacology of immunosuppressive drugs. Pharmacology for Physicians 2(8): 1-6

Dundee, J.W. 1971: The pharmacology of intravenous anaesthetic agents. Annals of the Royal College of Surgeons of England 48(1): 37-38

Gluckman, M.I.; Baum, T. 1969: The pharmacology of iprindole, a new antidepressant. Psychopharmacologia 15(3): 169-185

Dawson, W.; Sweatman, W.J. 1980: The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound. British Journal of Pharmacology 71(2): 387-398

Linde, H.W. 1974: The pharmacology of isoflurane and enflurane. Aana Journal 42(6): 523-534

Pindell, M.H. 1966: The pharmacology of kanamycin--a review and new developments. Annals of the new York Academy of Sciences 132(2): 805-810

Greenwood, C. 1982: The pharmacology of ketotifen. Chest 82(1 Suppl): 45s-48s

Kappeler, H. 1966: The pharmacology of lipolysis inhibition. I. Mechanism of action of adenosine-containing nucleosides and nucleotides in adipose tissue lipolysis in vitro. Diabetologia 2(1): 52-61

Alps, B.J.; Harry, T.V.; Southgate, P.J. 1973: The pharmacology of lorazepam, a broad-spectrum tranquillizer. Current Medical Research and Opinion 1(5): 239-261

Hollingsworth, M.; Gilfillan, A.M. 1984: The pharmacology of lung surfactant secretion. Pharmacological Reviews 36(2): 69-90

Eyberg, C.; Moodley, G.P.; Buchanan, N. 1974: The pharmacology of malnutrition. Part I. Salicylate binding studies using normal serum/plasma and kwashiorkor serum. South African Medical Journal 48(61): 2564-2567

Borodkin, I.S.; Zaĭtsev, I.V. 1984: The pharmacology of memory (results and prospects). Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova 70(7): 983-989

Marshall, R.J. 1983: The pharmacology of mianserin--an update. British Journal of Clinical Pharmacology 15 Suppl. 2: 263s-268s

Savarese, J.J.; Ginsburg, S.; Lee, S.M.; Kitz, R.J. 1973: The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications. Anesthesia and Analgesia 52(6): 982-988

Taylor, W.J. 1968: The use and abuse of intravenous procaine. Applied Therapeutics 10(8): 513-516

Van der Vies, J. 1982: The pharmacology of oestriol. Maturitas 4(4): 291-299

Kirby, W.M.; Gordon, R.C.; Reagamey, C. 1974: The pharmacology of orally administered amoxicillin and ampicillin. Journal of Infectious Diseases 129(0 Suppl): s154-155

Harpur, E.S. 1982: The pharmacology of ototoxic drugs. British Journal of Audiology 16(2): 81-93

Buckett, W.R.; Marjoribanks, C.E.; Marwick, F.A.; Morton, M.B. 1968: The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent. British Journal of Pharmacology and ChemoTherapy 32(3): 671-682

Buckett, W.R. 1968: The pharmacology of pancuronium bromide: a new non-depolarising neuromuscular blocking agent. Irish Journal of Medical Science 7(12): 565-568

Koe, B.K.; Weissman, A. 1968: The pharmacology of para-chlorophenylalanine, a selective depletor of serotonin stores. Advances in Pharmacology 6(Part B): Suppl 1: 29-47

Klawans, H.L. 1968: The pharmacology of parkinsonism (a review). Diseases of the Nervous System 29(12): 805-816

Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H.; Lenaerts, F.M.; Verbruggen, F.J.; Van Nueten, J.M.; Schaper, W.K. 1970: The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug. European Journal of Pharmacology 11(2): 139-154

Weiss, H.J. 1972: The pharmacology of platelet inhibition. Progress in Hemostasis and Thrombosis 1: 199-231

Fitzgerald, J.D. 1972: The pharmacology of practolol, a cardioselective beta adrenergic blocking drug. Acta Cardiologica Suppl 16: 1-18

Cavero, I.; Roach, A.G. 1980: The pharmacology of prazosin, a novel antihypertensive agent. Life Sciences 27(17): 1525-1540

Davey, M.J. 1982: The pharmacology of prazosin, an alpha 1-adrenoceptor antagonist and the basis for its use in the treatment of essential hypertension. Clinical and Experimental Hypertension. Part A Theory and Practice 4(1-2): 47-59

Foster, R.W. 1966: The pharmacology of pressor drugs. British Journal of Anaesthesia 38(9): 690-704

Clarke, A.K. 1983: The pharmacology of pressure sores. International Rehabilitation Medicine 5(2): 75

Hadfield, A.F.; Sartorelli, A.C. 1984: The pharmacology of prodrugs of 5-fluorouracil and 1-beta-D-arabinofuranosylcytosine. Advances in Pharmacology and ChemoTherapy 20: 21-67

Brenner, P.F. 1982: The pharmacology of progestogens. Journal of Reproductive Medicine 27(8 Suppl): 490-497

Yates, R.A.; Middlemiss, D.N. 1981: The pharmacology of propranolol. American Journal of Psychiatry 138(3): 395

Oelssner, W. 1966: The pharmacology of psychopharmaca. Pharmazeutische Praxis 2: 25-29

Nicoll, R.A.; Barker, J.L. 1971: The pharmacology of recurrent inhibition in the supraoptic neurosecretory system. Brain Research 35(2): 501-511

Morozova, N.I. 1965: The pharmacology of rhododendron L. (rose bay). Farmakologiia i Toksikologiia 28(4): 436-438

Buchanec, J.; Visnovský, P.; Galanda, V.; Antonyová, M. 1982: The pharmacology of salicylates. VI. its effect on the kidneys and water and salt metabolism. Ceskoslovenska Pediatrie 37(2): 62-65

Bergofsky, E.H. 1974: The pharmacology of severe bronchial asthma. American Journal of the Medical Sciences 267(4): 225-227

Wang, N.C.; Li, Y.S.; Chang, S.S.; Fu, S.X. 1965: The pharmacology of sinomenine. VI. the mode of antiphlogistic action in rats. Yao Xue Xue Bao 12(8): 487-491

Feng, C.I.; Chin, Y.; Wang, N.C.; Chang, S.S. 1965: The pharmacology of sinomenine. VII. Effect of sinomenine on the gastro-intestinal movement and its mechanism. Yao Xue Xue Bao 12(8): 492-495

Vargaftig, B.B.; Vargaftig, B.B. 1994: The pharmacology of slow reacting substance C and of arachidonic acid. 1973. Agents and Actions 43(3-4): 158-166; Discussion 167

Shevchenko, A.I. 1967: The pharmacology of smooth muscle tissue. Progress in Brain Research 20: 283-296

Zsámboki, G. 1994: The pharmacology of sodium cromoglycate. Therapia Hungarica 42(1): 37-40

Zakusov, V.V. 1965: The pharmacology of sodium hydroxybutyrate. Eksperimental'naia Khirurgiia i Anesteziologiia 10(3): 66-69

Stern, P.; Gmaz-Nikulin, E. 1971: The pharmacology of spermidine. Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 24: 43-50

Curtis, D.R. 1969: The pharmacology of spinal postsynaptic inhibition. Progress in Brain Research 31: 171-189

Gemmill, C.L. 1974: The pharmacology of squill. Bulletin of the new York Academy of Medicine 50(6): 747-750

Rüegg, M. 1980: The pharmacology of sulfinpyrazone (Anturan). Wiener Medizinische Wochenschrift. Suppl 61: 3-8

Skillman, T.G.; Feldman, J.M. 1981: The pharmacology of sulfonylureas. American Journal of Medicine 70(2): 361-372

Gelber, R.H.; Gooi, H.C.; Waters, M.F.; Rees, R.J. 1974: The pharmacology of sulphetrone and its implications in sulphone resistance. Leprosy Review 45(4): 308-312

O'Connor, S.E.; Brown, R.A. 1982: The pharmacology of sulpiride--a dopamine receptor antagonist. General Pharmacology 13(3): 185-193

Klawans, H.L. 1973: The pharmacology of tardive dyskinesias. American Journal of Psychiatry 130(1): 82-86

Sharapov, I.M. 1972: The pharmacology of temechine--a new ganglionic blocking preparation. Farmakologiia i Toksikologiia 35(6): 687-690

Phillis, J.W. 1971: The pharmacology of thalamic and geniculate neurons. International Review of Neurobiology 14: 1-48

Leonard, B.E. 1967: The pharmacology of the alkaloids from Pithecolobium saman (Benth). 2. Central effects. Archives Internationales de Pharmacodynamie et de Therapie 166(2): 435-448

Leonard, B.E.; Sherratt, H.S. 1967: The pharmacology of the alkaloids from Pithecolobium saman (Benth.). 1. Peripheral effects. Archives Internationales de Pharmacodynamie et de Therapie 166(2): 424-434

Leonard, B.E.; Sherratt, H.S. 1967: The pharmacology of the alkaloids from Pithecolobium saman (Benth.). 3. Biochemical and toxicological effects. Archives Internationales de Pharmacodynamie et de Therapie 167(2): 420-430

Sonntag, A.C.; Stenger, V.G.; Vogh, B.P.; Maren, T.H. 1972: The pharmacology of the antimalarial drug 4,4'-diformamidodiphenylsulfone (DFD) in dog and monkey. Journal of Pharmacology and Experimental Therapeutics 182(1): 34-47

Hunsicker, L.G. 1969: The pharmacology of the antimalarials. a rational approach to the therapy of resistant falciparum malaria. Archives of Internal Medicine 123(6): 645-649

Waser, P.G. 1967: The pharmacology of the calabash alkaloids. Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften 22(5): 486-500

Zechel, V.H.; Brock, N. 1974: The pharmacology of the combination drug dilazep/beta-acetyldigoxin. Arzneimittel-Forschung 24(11a Suppl): 1905-1914

Myers, C.E. 1981: The pharmacology of the fluoropyrimidines. Pharmacological Reviews 33(1): 1-15

Sachs, G.; Shin, J.M.; Briving, C.; Wallmark, B.; Hersey, S. 1995: The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annual Review of Pharmacology and Toxicology 35: 277-305

Drews, J. 1984: The pharmacology of the immune system: clinical and experimental perspectives. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 28: 83-109

Riker, W.F. 1972: The pharmacology of the neostigmine-like facilitatory drug effect at the mammalian neuromuscular junction. Japanese Journal of Pharmacology 22: Suppl 22: 1

Gray, T.C. 1971: The pharmacology of the newer anaesthetic agents. Introduction. Annals of the Royal College of Surgeons of England 48(1): 37

McBain, A.E.; Wheal, H.V.; Collins, J.F. 1984: The pharmacology of the piperidine dicarboxylates on the crustacean neuromuscular junction. Neuropharmacology 23(1): 23-30

Cohen, S. 1966: The pharmacology of the psychoactive drugs. Northwest Medicine 65(3): 197-203

Featherstone, R.M.; Settle, W. 1974: The pharmacology of the rare gases (helium, neon, argon, krypton, xenon). Actualites Pharmacologiques 27: 69-86

Ancill, R.J.; Jackson, D.M.; Redfern, P.H. 1972: The pharmacology of the rat ureter in vivo. British Journal of Pharmacology 44(4): 628-633

Simon, G.I. 1981: The pharmacology of topical steroids. Occupational Health and Safety 50(5): 35-36; 58

Altinkurt, O. 1971: The pharmacology of typhoid antigens. Turk Hijiyen Ve Tecrubi Biyoloji Dergisi 31(1): 14-24

Dominic, J.A.; Bourne, D.W.; Tan, T.G.; Kirsten, E.B.; McAllister, R.G. 1981: The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration. Journal of Cardiovascular Pharmacology 3(1): 25-38

Ogren, S.O.; Ross, S.B.; Hall, H.; Holm, A.C.; Renyi, A.L. 1981: The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor. Acta Psychiatrica Scandinavica. Supplementum 290: 127-151

Barrett, A.M. 1970: The pharmacology of "inderal" (propranolol hydrochloride). Bruxelles Medical 50(9): 577-582

Lozzi, C. 1965: The pharmacopoeia of the USSR. Produits and Problemes Pharmaceutiques 20(5): 249-251

Marini-Bettolo, G.B. 1966: The pharmacopoeia yesterday, today and tomorrow. Il Farmaco; Edizione Pratica 21(1): 3-21

Asakawa, Y. 1969: The pharmacoradiographic studies of the colon by Metoclopramide and Hyoscin-N-butylbromide. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 29(2): 185-219

Bausch, J. 1995: The pharmacotherapy circle--a promising way for improving quality in primary medical care. Zeitschrift für Arztliche Fortbildung 89(4): 406-414

Caine, E.D. 1980: The pharmacotherapy of Tourette syndrome. International Journal of Neurology 14(1): 123-126

Friedel, R.O. 1980: The pharmacotherapy of depression in the elderly: pharmacokinetic considerations. Proceedings of the Annual Meeting of the American Psychopathological Association 69: 157-165

Shopsin, B.; Waters, B. 1980: The pharmacotherapy of major depressive syndrome. Part 1: treatment of acute depression. Psychosomatics 21(7): 542-556

Shopsin, B.; Waters, B. 1980: The pharmacotherapy of major depressive syndrome. Part 2: Prophylaxis of recurrent depressive illness. Psychosomatics 21(8): 649

Nilsson, J.L. 1969: The pharmacotherapy of rheumatoid diseases (1): a chemical survey. Lakartidningen 66(Suppl 3): 48-52

Boström, H. 1969: The pharmacotherapy of rheumatoid diseases (2): the action of anti-rheumatic drugs on the synthesis of certain connective tissue components. Lakartidningen 66(Suppl 3): 53-55

Edström, B.; Sjöqvist, F. 1969: The pharmacotherapy of rheumatoid diseases (3): clinical pharmacological points of view. Lakartidningen 66(Suppl 3): 56-61

Olhagen, B. 1969: The pharmacotherapy of rheumatoid diseases (4): pathogenesis of inflammation of the joints. Lakartidningen 66(Suppl 3): 62-72

Gullberg, R. 1969: The pharmacotherapy of rheumatoid diseases (5): salicylates, butazone preparations and indomethacin. Lakartidningen 66(Suppl 3): 73-77

Berglund, K. 1969: The pharmacotherapy of rheumatoid diseases (6): chloroquine preparations. Lakartidningen 66(Suppl 3): 78-85

Segatore, M.; Miller, M. 1994: The pharmacotherapy of spinal spasticity: a decade of progress I. Theoretical aspects. Sci Nursing: a Publication of the American Association of Spinal Cord Injury Nurses 11(3): 66-69

Segatore, M.; Miller, M. 1995: The pharmacotherapy of spinal spasticity: a decade of progress. II. Therapeutics. Sci Nursing: a Publication of the American Association of Spinal Cord Injury Nurses 12(1): 2-7

Brodsky, C.M. 1970: The pharmacotherapy system. Psychosomatics 11(1): 24-30

Beitman, B.D.; Chiles, J.; Carlin, A. 1984: The pharmacotherapy-psychotherapy triangle: psychiatrist, nonmedical psychotherapist, and patient. Journal of Clinical Psychiatry 45(11): 458-459

Gildemeister, B. 1965: The pharmacy and disinfection measures in the university clinics (Charité) in Berlin. Pharmazeutische Praxis 5: 112-113

Moore, T.D.; Dzierba, S.H.; Miller, A. 1984: The pharmacy computer system at The Ohio State University hospitals. American Journal of Hospital Pharmacy 41(11): 2384-2389

Gouveia, W.A.; Mildenberger, J.M.; Decker, E.L.; Vitus, L. 1984: The pharmacy computer system at the new England Medical Center. American Journal of Hospital Pharmacy 41(9): 1813-1823

Hodapp, W.J. 1969: The pharmacy exhibit. Journal of the American Pharmaceutical Association 9(5): 227-230

Anonymous 1966: The pharmacy in Krylbo. Svensk Farmaceutisk Tidskrift 70(22): 541

Lindskog, E. 1966: The pharmacy in Lindesberg. An example of modern Swedish pharmacy planning. Svensk Farmaceutisk Tidskrift 70(9): 239-256

Parker, H.E. 1974: The pharmacy in a university atmosphere. Journal of the American College Health Association 23(2): 181-183

Goedhart, P.J. 1984: The pharmacy in small animal practice. Tijdschrift Voor Diergeneeskunde 109(1): 20-24

Rogers, J.O. 1969: The pharmacy law as it applies to handling of drugs. Journal of the American College Health Association 18(2): 165

Gouveia, W.A. 1972: The pharmacy module. American Journal of Hospital Pharmacy 29(7): 584-585

Ríha, K. 1980: The pharmacy network in relation to the network of other health facilities. Ceskoslovenske Zdravotnictvi 28(12): 526-531

Aminov, U.U. 1970: The pharmacy of communist labor. Farmatsiia 19(3): 60-61

Fifková, V.; Solich, J. 1984: The pharmacy profession in our society. I. Problems with professional prestige and with the evaluation of opinions of students and graduates of pharmacy schools. Ceskoslovenska Farmacie 33(1): 27-29

Ducharme, P. 1984: The pharmacy service at the Laval City of Health: a dual vocation. L'Union Medicale du Canada 113(9): 772-775

Provost, G.P. 1973: The pharmacy service corporation: a new dimension in hospital pharmacy. American Journal of Hospital Pharmacy 30(8): 671

Adler, D.S. 1969: The pharmacy student and social responsibility. Journal of the American Pharmaceutical Association 9(6): 284-285

Ingwersen, F. 1974: The pharmakokinetics of 3H-digitoxin and its metabolites in the guinea-pig. Naunyn-Schmiedeberg's Archives of Pharmacology 282(Suppl): R38

Henschler, D.; Hempel, K.; Schultze, B.; Maurer, W. 1971: The pharmakokinetics of escin. Arzneimittel-Forschung 21(11): 1682-1692

Evans, M.E.; Paterson, J.W.; Shenfield, G.M.; Thomas, N.; Walker, S.R. 1973: The pharmokinetics of rimiterol in asthmatic patients. British Journal of Pharmacology 49(1): 153P-154P

Morris, H.L.; Spriestersbach, D.C. 1967: The pharyngeal flap as a speech mechanism. Plastic and Reconstructive Surgery 39(1): 66-70

Skoog, T. 1966: The pharyngeal flap operation for cleft palate patients. Journal of the American Medical Women's Association 21(12): 1022-1027

Calloway, N.O.; Kujak, R.J. 1966: The pharyngeal flora of aged patients: effect of a penicillin (sodium nafcillin) administered orally. Journal of the American Geriatrics Society 14(12): 1261-1264

McGrath, P. 1973: The pharyngeal hypophysis in the laboratory animal. Journal of Anatomy 116(Part 3): 466

McGrath, P. 1970: The pharyngeal hypophysis in the under-fifty age group. Journal of Anatomy 106(Part 1): 198

Diebold, N.; Nezelof, C. 1971: The pharyngeal lymphoid tissue in children. Data given by immunofluorescent study. La Presse Medicale 79(46): 2051-2056 Passim

Borgo, M.; Conti, A.; Perani, G. 1965: The pharyngeal mucosa in senescence. Histochemical and histoenzymologic study. Archivio Italiano di Otologia Rinologia e Laringologia 76(4): 551-564

Marks, S.M.; Ross, M. 1972: The pharyngeal pituitary in the Chacma baboon (Papio ursinus). Central African Journal of Medicine 18(8): 157-159

Reynolds, D.F. 1983: The pharyngeal stage of deglutition in patients with dysphagia. British Journal of Radiology 56(663): 215

Niemann, J.T.; Rosborough, J.P.; Myers, R.; Scarberry, E.N. 1984: The pharyngeo-tracheal lumen airway: preliminary investigation of a new adjunct. Annals of Emergency Medicine 13(8): 591-596

Grünebaum, M.; Nutman, J.; Nitzan, M. 1981: The pharyngo-laryngeal deficit in the acute form of infantile spinal muscular atrophy (Werdnig-Hoffmann disease). Pediatric Radiology 11(2): 67-70

Winans, C.S. 1972: The pharyngoesophageal closure mechanism: a manometric study. Gastroenterology 63(5): 768-777

Ekberg, O.; Olsson, R. 1995: The pharyngoesophageal segment. Der Radiologe 35(10): 689-692

Siirala, U.; Lauerma, S.; Raivio, M.; Sjöblom, C.J. 1972: The pharyngolarynx: new aspects of the use of the larynx for reconstruction in hypopharyngeal carcinoma. Laryngoscope 82(3): 504-509

Parke, W.W.; Rothman, R.H.; Brown, M.D. 1984: The pharyngovertebral veins: an anatomical rationale for Grisel's syndrome. Journal of Bone and Joint Surgery. American Volume 66(4): 568-574

Jing, B.S. 1974: The pharynx and larynx: roentgenographic technique. Seminars in Roentgenology 9(4): 259-265

Ahmann, D.L. 1972: The phase II study: some reflections, particularly concerning disseminated breast cancer. Cancer ChemoTherapy Reports. Part 3 3(1): 29-32

Yost, W.A.; Grantham, D.W.; Lutfi, R.A.; Stern, R.M. 1982: The phase angle of addition in temporal masking for diotic and dichotic listening conditions. Hearing Research 7(3): 247-259

Shipley, G.G.; Green, J.P.; Nichols, B.W. 1973: The phase behavior of monogalactosyl, digalactosyl, and sulphoquinovosyl diglycerides. Biochimica et Biophysica Acta 311(4): 531-544

Arrotta, U.; Stradella, P.; Volpe, L. 1980: The phase contrast microscope. Cyto-hormonal evaluation of normal pregnancy at term and of prolonged and high-risk pregnancy. Minerva Ginecologica 32(1-2): 91-100

Nixon, J.R.; Ul Haque, R.S.; Carless, J.E. 1971: The phase diagram of cetomacrogol 1000-water-benzaldehyde in the presence of gallate antioxidants. Journal of Pharmacy and Pharmacology 23(1): 1-7

Kim, M. 1971: The phase diagrams and metallic materials. Ch'ikwa Kijae Hakhoe Chi. Journal of the Korea Research Society for Dental Materials 5(1): 5-13

Ogura, H. 1971: The phase formed in silver-twin amalgam. Shika Rikogaku Zasshi. Journal of the Japan Society for Dental Apparatus and Materials 12(25): 197-204

Nagasawa, N. 1967: The phase microcinematographic observation on cultivated cell from the mice gingiva-tissue. Kyoto Daigaku Kokukagaku Kiyo. Bulletin of Stomatology Kyoto University 7(2): 77-121

Corn, H. 1971: The phase microscope. An aid to "turn them on". Journal of the Ontario Dental Association 48(10): 304-306

Arslan, S.H.; Mackenzie, C.P.; Brown, R.; Baxter, J.T. 1983: The phase of hair growth in hypothyroidism in the dog. Veterinary Research Communications 6(1): 51-58

Jilge, B. 1984: The phase relation between a circadian rhythm of the rabbit and different light: dark time ratios. Zeitschrift für Versuchstierkunde 26(3): 111-122

Kenner, T.; Wetterer, E.; Priebe, L.; Schlüssel, H.; Schulte, M. 1966: The phase relations between pressure pulsations and the cross-section of arteries. With a discussion of the paper of L. Priebe, H. Schlüssel and M. Schulte, "Hemorheologic observations on rheography". Archiv für Kreislaufforschung 51(1): 160-167

Umezurike, G.M.; Iheanacho, E.N. 1984: The phase relationship of glycogen and free fatty acids in tissues of aestivating giant African snails (Achatina achatina). Comparative Biochemistry and Physiology. B Comparative Biochemistry 78(2): 461-466

Kakhnovskiĭ, I.M.; Shiian, I.V.; Grishina, I.M. 1971: The phase structure of cardiac contraction in diabetes mellitus patients. Terapevticheskii Arkhiv 43(8): 51-54

Vasil'tsev, I.S.; Plotnikova, N.D.; Pekarskiĭ, V.V. 1970: The phase structure of left ventricular systole in rheumatic mitral heart defects. Kardiologiia 10(6): 130-133

Zonis, B.I. 1974: The phase structure of the cardiac cycle according to kinetocardiographic findings in dogs during postnatal ontogenesis. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 10(4): 357-360

Strongin, G.L.; Sysoev, V.M. 1968: The phase structure of the heart systole in healthy flight personnel and in flight personnel with atherosclerosis. Voenno-Meditsinskii Zhurnal 10: 66-69

Nakagaki, M.; Naito, Y. 1972: The phase transition of cholesteryl esters and variation of dielectric properties. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 92(10): 1225-1232

Yang, T.; Levy, M.N. 1984: The phase-dependency of the cardiac chronotropic responses to vagal stimulation as a factor in sympathetic-vagal interactions. Circulation Research 54(6): 703-710

Colton, J.S.; Lovelace, D.E.; Davis, J.D.; Anderson, G.J.; Freeman, A.R. 1974: The phase-plane cardiogram: preliminary findings on a healthy population. American Heart Journal 87(5): 619-626

Serbezov, V.; Delivichev, I. 1974: The phases of Coxiella burneti and its immunosorbents. Journal of Hygiene Epidemiology Microbiology and Immunology 18(1): 96-99

Gould, R.L. 1972: The phases of adult life: a study in developmental psychology. American Journal of Psychiatry 129(5): 521-531

Stahl, D.A. 1995: The phases of managed care: where does subacute care fit?. Nursing Management 26(5): 16-17

Veress, B.; Kerényi, T.; Hüttner, I.; Jellinek, H. 1966: The phases of muscle necrosis. Journal of Pathology and Bacteriology 92(2): 511-517

Luisada, A.A.; MacCanon, D.M. 1972: The phases of the cardiac cycle. American Heart Journal 83(5): 705-711

Polli, E. 1967: The phases of the clinical trials of a new drug. Recenti Progressi in Medicina 42(1): 1-32

Leggio, F.; Cassone, R.; Lucisano, V.; Gambelli, G.; Di Renzi, L. 1970: The phases of the left ventricular mechanical systole during the pharmacodynamic effect induced with atropine in normal subjects. Bollettino Della Societa Italiana di Cardiologia 14(6): 878-897

Kollath, W. 1967: The phases of the nutritional process; on the significance of mastication. Internationale Zeitschrift für Vitaminforschung. International Journal of Vitamin Research. Journal International de Vitaminologie 37(2): 212-225

Vasilevskiĭ, N.N.; Soroko, S.I. 1970: The phasic character of cortical neuron reactions and its functional significance for the transmission of excitation in afferent systems. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 20(4): 621-627

Roussel, J.P. 1973: The phasic difference of the heart rhythm in Locusta migratoria L. I. Larval form. Experientia 29(4): 433-435

Todorov, S.; Ivanov, B.; Mileva, M. 1973: The phasic radiosensitivity of human lymphocytes to the effects of protons. Eksperimentalna Meditsina i Morfologiia 12(3): 142-145

Gaarder, K.; Koresko, R.; Kropfl, W. 1966: The phasic relation of a component of alpha rhythm to fixation saccadic eye movements. Electroencephalography and Clinical Neurophysiology 21(6): 544-551

Vorob'ev, N.A.; Bakharev, B.V.; Pavlik, V.D.; Zhadin, M.N. 1994: The phasic relations between the rhythmic activities of the rabbit cortical structures at different frequencies of stimulation of the midbrain reticular formation. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 44(6): 1038-1045

Tivikova, O.P. 1972: The phasic structure of the cardiac cycle in patients with arterial hypotension. Kardiologiia 12(12): 102-103

Skriabina, E.N. 1984: The phasic syndrome of hypodynamic of the left ventricle of the heart in pregnant women. Vrachebnoe Delo 5: 73-75

Pribe, W.A. 1970: The phenacetin enigma. Journal of the American Geriatrics Society 18(9): 703-707

Bräunlich, H.; Greger, J.; Traeger, A. 1966: The phenelzine poisoning and the possibilities of its treatment in animal experiments. Zeitschrift für Arztliche Fortbildung 60(15): 914-921

Lee, G.L. 1973: The phenogenetics of a super-suppressor in Drosophila melanogaster. 3. Suppression at individual loci. Australian Journal of Biological Sciences 26(4): 903-909

Thieme, H. 1965: The phenol glycosides of salicaceous plants. 4. Review of newly isolated glycosides and new work on structural information; proof and determination of new glycosides. Die Pharmazie 20(7): 436-439

Thieme, H. 1965: The phenol glycosides of salicaceous plants. 6. Studies on seasonal changes in glycoside concentrations, on the dependency of glycoside content on the time of day and age of the plant organs. Die Pharmazie 20(11): 688-691